Warning message:
package 'XML' was built under R version 3.3.2 
Warning message:
package 'ggplot2' was built under R version 3.3.2 
Warning message:
package 'data.table' was built under R version 3.3.2 
Warning message:
package 'caret' was built under R version 3.3.2 
Warning message:
package 'coda' was built under R version 3.3.2 
Warning message:
package 'ggbeeswarm' was built under R version 3.3.2 
Registering 3 cores.
mkdir: output/: File exists
Logging in
Please upgrade to the latest version of the Synapse Client, 1.14-3, by running the following commands:
	source('http://depot.sagebase.org/CRAN.R')
	pkgInstall("synapseClient")

Here are this version's release notes:
https://sagebionetworks.jira.com/issues/?jql=project%20%3D%20SYNR%20AND%20fixVersion%20in%20(R-1.14-0%2C%20R-1.14-1%2C%20R-1.14-2%2C%20R-1.14-3)%20ORDER%20BY%20key%20DESC

To upload files to a private AWS S3 bucket, you must use version 1.8 (or later).

Welcome brian.white!
Logged in
Reading clinical data
Reading CMS results
Read 83 records
Read 5691 items
12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182831
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Reading bindea
Reading CIRC signature
Reading TCIA Neoantigens
Reading TCGA data
Reading KFS data
doaffy reading file: /Users/Brian/work/sage/middleton/input/KFSYSCC_frma_expression.tsv
Read 73.2% of 54675 rowsRead 54675 rows and 323 (of 323) columns from 0.277 GB file in 00:00:03
Number of rows analyzed: 20294
Number of columns analyzed: 344
tcga-gene-sets: 28 of 34 genes from data set analyzed in set B cells: MS4A1 TCL1A HLA-DOB PNOC KIAA0125 CD19 CR2 FCRL2 BLK COCH OSBPL10 TNFRSF17 ABCB4 BLNK GLDC MEF2C SPIB BCL11A GNG7 CD72 MICAL3 BACH2 CCR9 QRSL1 DTNB HLA-DQA1 SCN3A SLC15A2
tcga-gene-sets: 6 of 34 genes missing from data set analyzed in set B cells: IGHG1 IGHA1 IGHM FAM30A IGKC IGL@
tcga-gene-sets: 16 of 18 genes from data set analyzed in set T cells: PRKCQ CD3D CD3G CD28 LCK TRAT1 BCL11B CD2 ITM2A SH2D1A CD6 CD96 NCALD GIMAP5 CD3E SKAP1
tcga-gene-sets: 2 of 18 genes missing from data set analyzed in set T cells: TRBC1 TRA@
tcga-gene-sets: 27 of 27 genes from data set analyzed in set Th1 cells: IFNG LTA APBB2 DOK5 IL12RB2 APOD ZBTB32 CD38 CSF2 CTLA4 CD70 DPP4 EGFL6 BST2 DUSP5 LRP8 IL22 DGKI CCL4 GGT1 LRRN3 SYNGR3 ATP9A BTG3 CMAH HBEGF SGCB
tcga-gene-sets: 26 of 27 genes from data set analyzed in set Th2 cells: PMCH AHI1 PTGIS CXCR6 EVI5 IL26 MB NEIL3 GSTA4 PHEX SMAD2 CENPF ANK1 ADCY1 LAIR2 SNRPD1 MICAL2 DHFR WDHD1 BIRC5 SLC39A14 HELLS LIMA1 CDC25C CDC7 GATA3
tcga-gene-sets: 1 of 27 genes missing from data set analyzed in set Th2 cells: AI582773
tcga-gene-sets: 16 of 17 genes from data set analyzed in set Cytotoxic cells: KLRD1 KLRF1 GNLY CTSW KLRB1 KLRK1 NKG7 GZMH SIGIRR ZBTB16 RUNX3 APOL3 RORA APBA2 DUSP2 GZMA
tcga-gene-sets: 1 of 17 genes missing from data set analyzed in set Cytotoxic cells: WHDC1L1
tcga-gene-sets: 30 of 31 genes from data set analyzed in set iDC: CD1B VASH1 F13A1 CD1E MMP12 FABP4 CLEC10A SYT17 MS4A6A CTNS GUCA1A CARD9 ABCG2 CD1A PPARG RAP1GAP SLC7A8 GSTT1 FZD2 CSF1R HS3ST2 CH25H LMAN2L SLC26A6 BLVRB NUDT9 PREP TM7SF4 TACSTD2 CD1C
tcga-gene-sets: 1 of 31 genes missing from data set analyzed in set iDC: NM_021941
tcga-gene-sets: 26 of 31 genes from data set analyzed in set Neutrophils: CSF3R CYP4F3 VNN3 KCNJ15 MME FCGR3B DYSF FCAR CEACAM3 HIST1H2BC HPSE CREB5 S100A12 TNFRSF10C SLC22A4 SLC25A37 BST1 CRISPLD2 G0S2 SIGLEC5 CD93 MGAM ALPL FPR1 PDE4B LILRB2
tcga-gene-sets: 5 of 31 genes missing from data set analyzed in set Neutrophils: FPRL1 IL8RA IL8RB FLJ11151 KIAA0329
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-gene-sets wnt vs CIRC: t = -7.66668942196379 df = 342 nrow = 344 cor = -0.3829621607261 pval = 1.84617074915233e-13
tcga-gene-sets tak1 vs CIRC: t = -1.90764957903146 df = 342 nrow = 344 cor = -0.102609400758207 pval = 0.0572738736909823
tcga-gene-sets wnt vs myc.sig: t = 29.5867669875905 df = 342 nrow = 344 cor = 0.847978818740452 pval = 2.60927229013165e-96

tcga-gene-sets: Analyzing B cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 14142, n_WT = 219, n_MT = 125, p = 0.608824327411549
tcga-gene-sets: Analyzing T cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 14788, n_WT = 219, n_MT = 125, p = 0.215001784047338
tcga-gene-sets: Analyzing Th1 cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15200, n_WT = 219, n_MT = 125, p = 0.0883179042343788
tcga-gene-sets: Analyzing Th2 cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13675, n_WT = 219, n_MT = 125, p = 0.989207748046283
tcga-gene-sets: Analyzing Cytotoxic cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15515, n_WT = 219, n_MT = 125, p = 0.0394550958525481
tcga-gene-sets: Analyzing iDC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15012, n_WT = 219, n_MT = 125, p = 0.135588232256003
tcga-gene-sets: Analyzing Neutrophils vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15981, n_WT = 219, n_MT = 125, p = 0.00974672529331536

Number of rows analyzed: 20534
Number of columns analyzed: 290
kfs-gene-sets: 31 of 34 genes from data set analyzed in set B cells: MS4A1 TCL1A HLA-DOB PNOC KIAA0125 CD19 CR2 IGHG1 FCRL2 BLK COCH OSBPL10 TNFRSF17 ABCB4 BLNK GLDC MEF2C IGHM SPIB BCL11A GNG7 IGKC CD72 MICAL3 BACH2 CCR9 QRSL1 DTNB HLA-DQA1 SCN3A SLC15A2
kfs-gene-sets: 3 of 34 genes missing from data set analyzed in set B cells: IGHA1 FAM30A IGL@
kfs-gene-sets: 16 of 18 genes from data set analyzed in set T cells: PRKCQ CD3D CD3G CD28 LCK TRAT1 BCL11B CD2 TRBC1 ITM2A SH2D1A CD6 CD96 NCALD CD3E SKAP1
kfs-gene-sets: 2 of 18 genes missing from data set analyzed in set T cells: TRA@ GIMAP5
kfs-gene-sets: 26 of 27 genes from data set analyzed in set Th1 cells: IFNG LTA APBB2 DOK5 IL12RB2 APOD ZBTB32 CD38 CSF2 CTLA4 CD70 DPP4 EGFL6 BST2 DUSP5 LRP8 IL22 DGKI CCL4 GGT1 LRRN3 SYNGR3 ATP9A BTG3 HBEGF SGCB
kfs-gene-sets: 1 of 27 genes missing from data set analyzed in set Th1 cells: CMAH
kfs-gene-sets: 26 of 27 genes from data set analyzed in set Th2 cells: PMCH AHI1 PTGIS CXCR6 EVI5 IL26 MB NEIL3 GSTA4 PHEX SMAD2 CENPF ANK1 ADCY1 LAIR2 SNRPD1 MICAL2 DHFR WDHD1 BIRC5 SLC39A14 HELLS LIMA1 CDC25C CDC7 GATA3
kfs-gene-sets: 1 of 27 genes missing from data set analyzed in set Th2 cells: AI582773
kfs-gene-sets: 15 of 17 genes from data set analyzed in set Cytotoxic cells: KLRD1 KLRF1 GNLY CTSW KLRB1 NKG7 GZMH SIGIRR ZBTB16 RUNX3 APOL3 RORA APBA2 DUSP2 GZMA
kfs-gene-sets: 2 of 17 genes missing from data set analyzed in set Cytotoxic cells: KLRK1 WHDC1L1
kfs-gene-sets: 28 of 31 genes from data set analyzed in set iDC: CD1B VASH1 F13A1 CD1E MMP12 FABP4 CLEC10A SYT17 MS4A6A CTNS GUCA1A ABCG2 CD1A PPARG RAP1GAP SLC7A8 GSTT1 FZD2 CSF1R HS3ST2 CH25H LMAN2L SLC26A6 BLVRB NUDT9 PREP TACSTD2 CD1C
kfs-gene-sets: 3 of 31 genes missing from data set analyzed in set iDC: CARD9 NM_021941 TM7SF4
kfs-gene-sets: 26 of 31 genes from data set analyzed in set Neutrophils: CSF3R CYP4F3 VNN3 KCNJ15 MME FCGR3B DYSF FCAR CEACAM3 HIST1H2BC HPSE CREB5 S100A12 TNFRSF10C SLC22A4 SLC25A37 BST1 CRISPLD2 G0S2 SIGLEC5 CD93 MGAM ALPL FPR1 PDE4B LILRB2
kfs-gene-sets: 5 of 31 genes missing from data set analyzed in set Neutrophils: FPRL1 IL8RA IL8RB FLJ11151 KIAA0329
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |                                                                              |=========                                                             |  12%  |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |                                                                              |==================                                                    |  25%  |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-gene-sets wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-gene-sets tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-gene-sets wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-gene-sets: Analyzing B cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10857, n_WT = 175, n_MT = 115, p = 0.255717542267841
kfs-gene-sets: Analyzing T cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9712, n_WT = 175, n_MT = 115, p = 0.616365843675602
kfs-gene-sets: Analyzing Th1 cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11184, n_WT = 175, n_MT = 115, p = 0.108569650276577
kfs-gene-sets: Analyzing Th2 cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9359, n_WT = 175, n_MT = 115, p = 0.314266782906259
kfs-gene-sets: Analyzing Cytotoxic cells vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11662, n_WT = 175, n_MT = 115, p = 0.0220858283559412
kfs-gene-sets: Analyzing iDC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9567, n_WT = 175, n_MT = 115, p = 0.478592754160238
kfs-gene-sets: Analyzing Neutrophils vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11974, n_WT = 175, n_MT = 115, p = 0.00622854051911139

Number of rows analyzed: 20294
Number of columns analyzed: 344
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-circ wnt vs CIRC: t = -7.66668942196379 df = 342 nrow = 344 cor = -0.3829621607261 pval = 1.84617074915233e-13
tcga-circ tak1 vs CIRC: t = -1.90764957903146 df = 342 nrow = 344 cor = -0.102609400758207 pval = 0.0572738736909823
tcga-circ wnt vs myc.sig: t = 29.5867669875905 df = 342 nrow = 344 cor = 0.847978818740452 pval = 2.60927229013165e-96

tcga-circ: Analyzing HLA-DQA1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15808, n_WT = 219, n_MT = 125, p = 0.0168630270833641
tcga-circ: Analyzing HLA-DQA2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15558, n_WT = 219, n_MT = 125, p = 0.035041481937021
tcga-circ: Analyzing HLA-DRB5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16044, n_WT = 219, n_MT = 125, p = 0.00791435794906807
tcga-circ: Analyzing CTLA4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15960, n_WT = 219, n_MT = 125, p = 0.0104366466521535
tcga-circ: Analyzing PDCD1LG2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16366, n_WT = 219, n_MT = 125, p = 0.00253892683604747
tcga-circ: Analyzing ICAM1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16853, n_WT = 219, n_MT = 125, p = 0.000360248172285815
tcga-circ: Analyzing CD274 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16180, n_WT = 219, n_MT = 125, p = 0.00496953367325217
tcga-circ: Analyzing STAT1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16069, n_WT = 219, n_MT = 125, p = 0.0072772800538876
tcga-circ: Analyzing IRF1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15380, n_WT = 219, n_MT = 125, p = 0.0564900708047821
tcga-circ: Analyzing IFNG vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15329, n_WT = 219, n_MT = 125, p = 0.0642763496059861
tcga-circ: Analyzing GNLY vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15711, n_WT = 219, n_MT = 125, p = 0.0225874412608977
tcga-circ: Analyzing TBX21 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16514, n_WT = 219, n_MT = 125, p = 0.00144502345464943
tcga-circ: Analyzing CCL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15276, n_WT = 219, n_MT = 125, p = 0.0734529316408623
tcga-circ: Analyzing LAG3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15535, n_WT = 219, n_MT = 125, p = 0.0373467551282688
tcga-circ: Analyzing CD247 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15908, n_WT = 219, n_MT = 125, p = 0.0123353892395922
tcga-circ: Analyzing ICOS vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16749.5, n_WT = 219, n_MT = 125, p = 0.000558622963071092
tcga-circ: Analyzing IL18RAP vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15826, n_WT = 219, n_MT = 125, p = 0.0159537672587926
tcga-circ: Analyzing CXCL9 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16432, n_WT = 219, n_MT = 125, p = 0.00198105152839399
tcga-circ: Analyzing CXCL10 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16218, n_WT = 219, n_MT = 125, p = 0.0043467533177559
tcga-circ: Analyzing HLA-DPB1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16098, n_WT = 219, n_MT = 125, p = 0.00659620530713424
tcga-circ: Analyzing HLA-DPA1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16643, n_WT = 219, n_MT = 125, p = 0.000865659270663289
tcga-circ: Analyzing HLA-DMB vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16365, n_WT = 219, n_MT = 125, p = 0.00254839221670098
tcga-circ: Analyzing HLA-DRA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16404, n_WT = 219, n_MT = 125, p = 0.00220233515414556
tcga-circ: Analyzing HLA-DMA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15994, n_WT = 219, n_MT = 125, p = 0.00934028438812116
tcga-circ: Analyzing CD80 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16345.5, n_WT = 219, n_MT = 125, p = 0.00273944982772266
tcga-circ: Analyzing HLA-DOA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15934, n_WT = 219, n_MT = 125, p = 0.0113508130289826
tcga-circ: Analyzing CD4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16386, n_WT = 219, n_MT = 125, p = 0.00235631909214539
tcga-circ: Analyzing HAVCR2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16371, n_WT = 219, n_MT = 125, p = 0.00249210246307242
tcga-circ: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15715, n_WT = 219, n_MT = 125, p = 0.0223216042395995

Number of rows analyzed: 20534
Number of columns analyzed: 290
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-circ wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-circ tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-circ wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-circ: Analyzing HLA-DQA1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10017, n_WT = 175, n_MT = 115, p = 0.948639587367541
kfs-circ: Analyzing CTLA4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11163, n_WT = 175, n_MT = 115, p = 0.115349956764405
kfs-circ: Analyzing PDCD1LG2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11281, n_WT = 175, n_MT = 115, p = 0.0812452489054197
kfs-circ: Analyzing ICAM1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12201, n_WT = 175, n_MT = 115, p = 0.00221011958860733
kfs-circ: Analyzing CD274 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11497, n_WT = 175, n_MT = 115, p = 0.0401017494728315
kfs-circ: Analyzing STAT1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13029, n_WT = 175, n_MT = 115, p = 2.17930782370407e-05
kfs-circ: Analyzing IRF1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11189, n_WT = 175, n_MT = 115, p = 0.10700270280949
kfs-circ: Analyzing IFNG vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11389, n_WT = 175, n_MT = 115, p = 0.0576825539239636
kfs-circ: Analyzing GNLY vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12368, n_WT = 175, n_MT = 115, p = 0.000968598990205333
kfs-circ: Analyzing TBX21 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10623, n_WT = 175, n_MT = 115, p = 0.422777432762042
kfs-circ: Analyzing CCL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11670, n_WT = 175, n_MT = 115, p = 0.0214289563579352
kfs-circ: Analyzing LAG3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12286, n_WT = 175, n_MT = 115, p = 0.00146204582090518
kfs-circ: Analyzing CD247 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11319, n_WT = 175, n_MT = 115, p = 0.0721926652054417
kfs-circ: Analyzing ICOS vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11741, n_WT = 175, n_MT = 115, p = 0.0163069072460512
kfs-circ: Analyzing IL18RAP vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10523, n_WT = 175, n_MT = 115, p = 0.510238094127099
kfs-circ: Analyzing CXCL9 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12185, n_WT = 175, n_MT = 115, p = 0.00238520193680007
kfs-circ: Analyzing CXCL10 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12348, n_WT = 175, n_MT = 115, p = 0.00107219740701228
kfs-circ: Analyzing HLA-DPB1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11479, n_WT = 175, n_MT = 115, p = 0.0426692441194827
kfs-circ: Analyzing HLA-DPA1 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12039, n_WT = 175, n_MT = 115, p = 0.00467600963773913
kfs-circ: Analyzing HLA-DMB vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11630, n_WT = 175, n_MT = 115, p = 0.0248915171379084
kfs-circ: Analyzing HLA-DRA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11462, n_WT = 175, n_MT = 115, p = 0.0452203950824153
kfs-circ: Analyzing HLA-DMA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11847, n_WT = 175, n_MT = 115, p = 0.0106582962972748
kfs-circ: Analyzing CD80 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11307, n_WT = 175, n_MT = 115, p = 0.0749575823358615
kfs-circ: Analyzing HLA-DOA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11565, n_WT = 175, n_MT = 115, p = 0.031552216569405
kfs-circ: Analyzing CD4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11808, n_WT = 175, n_MT = 115, p = 0.012493838846751
kfs-circ: Analyzing HAVCR2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11965, n_WT = 175, n_MT = 115, p = 0.00647669173947561
kfs-circ: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10654, n_WT = 175, n_MT = 115, p = 0.397560023143556

The following circ components are in the direction opposite the circ metagene
variable	pval.tcga	apval.tcga	mutUp.tcga	pval.kfs	apval.kfs	mutUp.kfs	val.tcga	val.kfs
Th2 cells	0.989207748046283	0.989207748046283	TRUE	0.314266782906259	0.439973496068762	TRUE	0.989207748046283	0.314266782906259
The following circ components are in the direction opposite the circ metagene
variable	pval.tcga	apval.tcga	mutUp.tcga	pval.kfs	apval.kfs	mutUp.kfs	val.tcga	val.kfs
T cells	0.215001784047338	0.301002497666273	FALSE	0.616365843675602	0.616365843675602	TRUE	0.215001784047338	0.616365843675602
Th2 cells	0.989207748046283	0.989207748046283	TRUE	0.314266782906259	0.439973496068762	TRUE	0.989207748046283	0.314266782906259
iDC	0.135588232256003	0.237279406448005	FALSE	0.478592754160238	0.558358213186944	TRUE	0.135588232256003	0.478592754160238
Using GeneSet as id variables
[1] -3 -2 -1  0  1  2  3
           GeneSet Dataset value
1          B cells    TCGA  0.61
2  Cytotoxic cells    TCGA  0.04
3      Neutrophils    TCGA  0.01
4          T cells    TCGA  0.22
5        Th1 cells    TCGA  0.09
6        Th2 cells    TCGA  0.99
7              iDC    TCGA  0.14
8          B cells KFSYSCC  0.26
9  Cytotoxic cells KFSYSCC  0.02
10     Neutrophils KFSYSCC  0.01
11         T cells KFSYSCC  0.62
12       Th1 cells KFSYSCC  0.11
13       Th2 cells KFSYSCC  0.31
14             iDC KFSYSCC  0.48
Scale for 'fill' is already present. Adding another scale for 'fill', which
will replace the existing scale.
[1] 3 2 1 0
[1] 3 2 1 0
The following circ components are in the direction opposite the circ metagene
variable	pval.tcga	apval.tcga	mutUp.tcga	pval.kfs	apval.kfs	mutUp.kfs	val.tcga	val.kfs
HLA-DQA1	0.0168630270833641	0.0222285357007981	FALSE	0.948639587367541	0.948639587367541	TRUE	0.0168630270833641	0.948639587367541
Using Gene as id variables
 [1] -5 -4 -3 -2 -1  0  1  2  3  4  5
       Gene Dataset value
1      CCL5    TCGA  0.07
2     CD247    TCGA  0.01
3     CD274    TCGA  0.00
4       CD4    TCGA  0.00
5      CD80    TCGA  0.00
6     CTLA4    TCGA  0.01
7    CXCL10    TCGA  0.00
8     CXCL9    TCGA  0.00
9      GNLY    TCGA  0.02
10   HAVCR2    TCGA  0.00
11  HLA-DMA    TCGA  0.01
12  HLA-DMB    TCGA  0.00
13  HLA-DOA    TCGA  0.01
14 HLA-DPA1    TCGA  0.00
15 HLA-DPB1    TCGA  0.01
16 HLA-DQA1    TCGA  0.02
17 HLA-DQA2    TCGA  0.04
18  HLA-DRA    TCGA  0.00
19 HLA-DRB5    TCGA  0.01
20    ICAM1    TCGA  0.00
21     ICOS    TCGA  0.00
22     IFNG    TCGA  0.06
23  IL18RAP    TCGA  0.02
24     IRF1    TCGA  0.06
25     LAG3    TCGA  0.04
26 PDCD1LG2    TCGA  0.00
27    STAT1    TCGA  0.01
28    TBX21    TCGA  0.00
29     CCL5 KFSYSCC  0.02
30    CD247 KFSYSCC  0.07
31    CD274 KFSYSCC  0.04
32      CD4 KFSYSCC  0.01
33     CD80 KFSYSCC  0.07
34    CTLA4 KFSYSCC  0.12
35   CXCL10 KFSYSCC  0.00
36    CXCL9 KFSYSCC  0.00
37     GNLY KFSYSCC  0.00
38   HAVCR2 KFSYSCC  0.01
39  HLA-DMA KFSYSCC  0.01
40  HLA-DMB KFSYSCC  0.02
41  HLA-DOA KFSYSCC  0.03
42 HLA-DPA1 KFSYSCC  0.00
43 HLA-DPB1 KFSYSCC  0.04
44 HLA-DQA1 KFSYSCC  0.95
46  HLA-DRA KFSYSCC  0.05
48    ICAM1 KFSYSCC  0.00
49     ICOS KFSYSCC  0.02
50     IFNG KFSYSCC  0.06
51  IL18RAP KFSYSCC  0.51
52     IRF1 KFSYSCC  0.11
53     LAG3 KFSYSCC  0.00
54 PDCD1LG2 KFSYSCC  0.08
55    STAT1 KFSYSCC  0.00
56    TBX21 KFSYSCC  0.42
Scale for 'fill' is already present. Adding another scale for 'fill', which
will replace the existing scale.
[1] 5 4 3 2 1 0
[1] 5 4 3 2 1 0
null device 
          1 
Warning messages:
1: In .local(expr, gset.idx.list, ...) :
  1genes with constant expression values throuhgout the samples.
2: In .local(expr, gset.idx.list, ...) :
  Since argument method!="ssgsea", genes with constant expression values are discarded.
3: In .local(expr, gset.idx.list, ...) :
  1genes with constant expression values throuhgout the samples.
4: In .local(expr, gset.idx.list, ...) :
  Since argument method!="ssgsea", genes with constant expression values are discarded.
Doing TCGA analysis
Number of rows analyzed: 20294
Number of columns analyzed: 344
tcga-all: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-all: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-all: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-all: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-all: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |====================================================                  |  75%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-all wnt vs CIRC: t = -7.66668942196379 df = 342 nrow = 344 cor = -0.3829621607261 pval = 1.84617074915233e-13
tcga-all tak1 vs CIRC: t = -1.90764957903146 df = 342 nrow = 344 cor = -0.102609400758207 pval = 0.0572738736909823
tcga-all wnt vs myc.sig: t = 29.5867669875905 df = 342 nrow = 344 cor = 0.847978818740452 pval = 2.60927229013165e-96
tcga-all CIRC vs neoantigens: t = 7.18856145436229 df = 340 nrow = 342 cor = 0.363227593412596 pval = 4.1846192883292e-12

tcga-all: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16382, n_WT = 219, n_MT = 125, p = 0.00239184964757301
tcga-all: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 14956, n_WT = 219, n_MT = 125, p = 0.152918117347929
tcga-all: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12675, n_WT = 219, n_MT = 125, p = 0.253980482313371
tcga-all: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15715, n_WT = 219, n_MT = 125, p = 0.0223216042395995
tcga-all: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12793, n_WT = 219, n_MT = 125, p = 0.31358705965474
tcga-all: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13241, n_WT = 219, n_MT = 125, p = 0.61515080317447
tcga-all: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12947, n_WT = 217, n_MT = 125, p = 0.48487310568218

tcga-all: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6373, n_CMS2 = 136, n_CMS1 = 51, p = 1.23959499498166e-18
tcga-all: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6318.5, n_CMS2 = 136, n_CMS1 = 51, p = 5.34572985361375e-18
tcga-all: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 4970, n_CMS2 = 136, n_CMS1 = 51, p = 5.24009718926665e-06
tcga-all: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6354, n_CMS2 = 136, n_CMS1 = 51, p = 2.06965323810782e-18
tcga-all: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1682, n_CMS2 = 136, n_CMS1 = 51, p = 6.07843507246058e-08
tcga-all: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 3171, n_CMS2 = 136, n_CMS1 = 51, p = 0.368407693350513
tcga-all: Analyzing neoantigens CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6531.5, n_CMS2 = 136, n_CMS1 = 51, p = 4.11558761110611e-21
tcga-all: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2261, n_CMS2 = 136, n_CMS3 = 42, p = 0.0416825581123066
tcga-all: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1448, n_CMS2 = 136, n_CMS3 = 42, p = 1.42195551760265e-06
tcga-all: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2038, n_CMS2 = 136, n_CMS3 = 42, p = 0.00510008881998723
tcga-all: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2169, n_CMS2 = 136, n_CMS3 = 42, p = 0.0186800531842814
tcga-all: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3902, n_CMS2 = 136, n_CMS3 = 42, p = 0.000341313512774918
tcga-all: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3320, n_CMS2 = 136, n_CMS3 = 42, p = 0.112311766739075
tcga-all: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2002.5, n_CMS2 = 136, n_CMS3 = 42, p = 0.00411497321796958
tcga-all: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2243, n_CMS2 = 136, n_CMS4 = 87, p = 5.51962791445972e-15
tcga-all: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2357, n_CMS2 = 136, n_CMS4 = 87, p = 3.67822638877412e-14
tcga-all: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3802, n_CMS2 = 136, n_CMS4 = 87, p = 6.88623146716682e-06
tcga-all: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2711, n_CMS2 = 136, n_CMS4 = 87, p = 9.19059090892192e-12
tcga-all: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 10043, n_CMS2 = 136, n_CMS4 = 87, p = 1.62745548681933e-18
tcga-all: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 9838, n_CMS2 = 136, n_CMS4 = 87, p = 7.16387570835703e-17
tcga-all: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5232.5, n_CMS2 = 136, n_CMS4 = 87, p = 0.217060840755576
tcga-all: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1136, n_CMS2 = 136, n_NOLBL = 28, p = 0.000796178954802526
tcga-all: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1162, n_CMS2 = 136, n_NOLBL = 28, p = 0.00119322424954628
tcga-all: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1564, n_CMS2 = 136, n_NOLBL = 28, p = 0.137894090993968
tcga-all: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1211, n_CMS2 = 136, n_NOLBL = 28, p = 0.00247521004049828
tcga-all: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2377, n_CMS2 = 136, n_NOLBL = 28, p = 0.0389311268873014
tcga-all: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2143, n_CMS2 = 136, n_NOLBL = 28, p = 0.297277254578888
tcga-all: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1671, n_CMS2 = 136, n_NOLBL = 28, p = 0.336323730744777


tcga-all: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 480, n_CMS2 = 41, n_CMS1 = 12, p = 2.03910940079564e-09
tcga-all: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 445, n_CMS2 = 41, n_CMS1 = 12, p = 3.42776539291469e-06
tcga-all: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 344, n_CMS2 = 41, n_CMS1 = 12, p = 0.0370659349500604
tcga-all: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 451, n_CMS2 = 41, n_CMS1 = 12, p = 1.32651563247495e-06
tcga-all: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 149, n_CMS2 = 41, n_CMS1 = 12, p = 0.0391350009745337
tcga-all: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 203, n_CMS2 = 41, n_CMS1 = 12, p = 0.371180469696714
tcga-all: Analyzing neoantigens CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 425.5, n_CMS2 = 41, n_CMS1 = 12, p = 0.000141818624469331
tcga-all: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 334, n_CMS2 = 41, n_CMS3 = 28, p = 0.00300622689012917
tcga-all: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 250, n_CMS2 = 41, n_CMS3 = 28, p = 4.38032568801522e-05
tcga-all: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 448, n_CMS2 = 41, n_CMS3 = 28, p = 0.125700872851552
tcga-all: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 335, n_CMS2 = 41, n_CMS3 = 28, p = 0.00313513226569386
tcga-all: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 875, n_CMS2 = 41, n_CMS3 = 28, p = 0.000161601913359647
tcga-all: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 783, n_CMS2 = 41, n_CMS3 = 28, p = 0.0101843523865015
tcga-all: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2 = 41, n_CMS3 = 28, p = 0.0859444272951382
tcga-all: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 111, n_CMS2 = 41, n_CMS4 = 27, p = 1.35462358863744e-09
tcga-all: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 108, n_CMS2 = 41, n_CMS4 = 27, p = 9.72860092552762e-10
tcga-all: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 302, n_CMS2 = 41, n_CMS4 = 27, p = 0.00136443856348936
tcga-all: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 110, n_CMS2 = 41, n_CMS4 = 27, p = 1.2138464426316e-09
tcga-all: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 986, n_CMS2 = 41, n_CMS4 = 27, p = 3.92922989387343e-09
tcga-all: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 1010, n_CMS2 = 41, n_CMS4 = 27, p = 2.74920522125321e-10
tcga-all: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2 = 41, n_CMS4 = 27, p = 0.616048341754066
tcga-all: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 129, n_CMS2 = 41, n_NOLBL = 17, p = 9.27819613872329e-05
tcga-all: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 187, n_CMS2 = 41, n_NOLBL = 17, p = 0.00516746377560274
tcga-all: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 227, n_CMS2 = 41, n_NOLBL = 17, p = 0.0378762896354627
tcga-all: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 133, n_CMS2 = 41, n_NOLBL = 17, p = 0.000128998098226766
tcga-all: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 474, n_CMS2 = 41, n_NOLBL = 17, p = 0.0317913947406518
tcga-all: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 426, n_CMS2 = 41, n_NOLBL = 17, p = 0.190309804419729
tcga-all: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2 = 41, n_NOLBL = 17, p = 0.0152617440877099

tcga-all: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1152, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.000163233994822283
tcga-all: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1630, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.132770432161197
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2000, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.805223570585009
tcga-all: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1323, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.00308528346316024
tcga-all: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2204, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.224749979645318
tcga-all: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2218, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.2004099792463
tcga-all: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2098, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.414530115017996
tcga-all: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 12, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 2.03910940079564e-09
tcga-all: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 47, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 3.42776539291469e-06
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 148, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.0370659349500604
tcga-all: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 41, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 1.32651563247495e-06
tcga-all: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 343, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.0391350009745337
tcga-all: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 289, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.371180469696714
tcga-all: Analyzing neoantigens CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 66.5, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.000141818624469331
tcga-all: Analyzing CIRC CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 42, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 5.96952388180639e-18
tcga-all: Analyzing HIF1A CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 63, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 2.00739053262276e-16
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 459, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.000886489206345325
tcga-all: Analyzing CIITA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 44, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 8.6088124778279e-18
tcga-all: Analyzing wnt CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1337, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 4.77918260103951e-08
tcga-all: Analyzing myc.sig CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 957, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.131266270713507
tcga-all: Analyzing neoantigens CMS2-MT vs CMS1-WT using Wilcoxon rank sum test with continuity correction: W = 44.5, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 3.78947701123408e-13
tcga-all: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 334, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00300622689012917
tcga-all: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 250, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 4.38032568801522e-05
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 448, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.125700872851552
tcga-all: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 335, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00313513226569386
tcga-all: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 875, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.000161601913359647
tcga-all: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 783, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0101843523865015
tcga-all: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0859444272951382
tcga-all: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 91, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 6.54057234168641e-05
tcga-all: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 78, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 1.62695186023443e-05
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 190, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.0617386209669866
tcga-all: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 114, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.000539102055503825
tcga-all: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 370, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.111601847559311
tcga-all: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 316, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.585875820946205
tcga-all: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 215.5, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.170032865744795
tcga-all: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 111, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 1.35462358863744e-09
tcga-all: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 108, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 9.72860092552762e-10
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 302, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.00136443856348936
tcga-all: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 1.2138464426316e-09
tcga-all: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 986, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 3.92922989387343e-09
tcga-all: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 1010, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 2.74920522125321e-10
tcga-all: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.616048341754066
tcga-all: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 173, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 2.74771126793874e-13
tcga-all: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 437, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 4.24062825237641e-08
tcga-all: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 877, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.0147806111464309
tcga-all: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 354, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 1.40844101480104e-09
tcga-all: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2163, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 1.12817482025658e-10
tcga-all: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2128, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 5.41250472810469e-10
tcga-all: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.844393016945285
tcga-all: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 129, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 9.27819613872329e-05
tcga-all: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 187, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.00516746377560274
tcga-all: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 227, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0378762896354627
tcga-all: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.000128998098226766
tcga-all: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 474, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0317913947406518
tcga-all: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 426, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.190309804419729
tcga-all: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0152617440877099
tcga-all: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 115, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0122113465867946
tcga-all: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 92, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.00205557554780918
tcga-all: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 257, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.492692949318259
tcga-all: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.038002252842376
tcga-all: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 301, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0931707380335296
tcga-all: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 281, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.221247642896345
tcga-all: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 329, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0209489707664498

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model with interaction for neoantigens
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-all: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 838, n_MT = 27, n_WT = 60, p = 0.800805944956622
tcga-all: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 780, n_MT = 27, n_WT = 60, p = 0.786657472927406
tcga-all: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 670, n_MT = 27, n_WT = 60, p = 0.200590727448065
tcga-all: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 688, n_MT = 27, n_WT = 60, p = 0.264967936293836
tcga-all: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 765, n_MT = 27, n_WT = 60, p = 0.683072479140494
tcga-all: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 807, n_MT = 27, n_WT = 60, p = 0.981700729741838
tcga-all: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 765, n_MT = 27, n_WT = 60, p = 0.772967967357958
tcga-all: Analyzing CIRC CMS1 MT vs WT using Wilcoxon rank sum test: W = 270, n_MT = 12, n_WT = 39, p = 0.435533110162582
tcga-all: Analyzing HIF1A CMS1 MT vs WT using Wilcoxon rank sum test: W = 245, n_MT = 12, n_WT = 39, p = 0.818044737273355
tcga-all: Analyzing BHLHE40 CMS1 MT vs WT using Wilcoxon rank sum test: W = 225, n_MT = 12, n_WT = 39, p = 0.852268856376717
tcga-all: Analyzing CIITA CMS1 MT vs WT using Wilcoxon rank sum test: W = 289, n_MT = 12, n_WT = 39, p = 0.229512386317868
tcga-all: Analyzing wnt CMS1 MT vs WT using Wilcoxon rank sum test: W = 152, n_MT = 12, n_WT = 39, p = 0.0699676294093422
tcga-all: Analyzing myc.sig CMS1 MT vs WT using Wilcoxon rank sum test: W = 222, n_MT = 12, n_WT = 39, p = 0.801054269531538
tcga-all: Analyzing neoantigens CMS1 MT vs WT using Wilcoxon rank sum test: W = 269, n_MT = 12, n_WT = 39, p = 0.448643825148328
tcga-all: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2743, n_MT = 41, n_WT = 95, p = 0.000163233994822283
tcga-all: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2265, n_MT = 41, n_WT = 95, p = 0.132770432161197
tcga-all: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1895, n_MT = 41, n_WT = 95, p = 0.805223570585009
tcga-all: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2572, n_MT = 41, n_WT = 95, p = 0.00308528346316024
tcga-all: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1691, n_MT = 41, n_WT = 95, p = 0.224749979645318
tcga-all: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1677, n_MT = 41, n_WT = 95, p = 0.2004099792463
tcga-all: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1756, n_MT = 41, n_WT = 95, p = 0.414530115017996
tcga-all: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 84, n_MT = 17, n_WT = 11, p = 0.677092675948511
tcga-all: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 112, n_MT = 17, n_WT = 11, p = 0.403501693661877
tcga-all: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 46, n_MT = 17, n_WT = 11, p = 0.025216702104574
tcga-all: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 17, n_WT = 11, p = 0.643498750592572
tcga-all: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 17, n_WT = 11, p = 1
tcga-all: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 17, n_WT = 11, p = 1
tcga-all: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 24, n_MT = 17, n_WT = 11, p = 0.00116033825466856
tcga-all: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 242, n_MT = 28, n_WT = 14, p = 0.227805142383617
tcga-all: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 253, n_MT = 28, n_WT = 14, p = 0.132909212242862
tcga-all: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 234, n_MT = 28, n_WT = 14, p = 0.321193129834995
tcga-all: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 232, n_MT = 28, n_WT = 14, p = 0.347887457660636
tcga-all: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 230, n_MT = 28, n_WT = 14, p = 0.375914690341709
tcga-all: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 233, n_MT = 28, n_WT = 14, p = 0.334372944037949
tcga-all: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 182, n_MT = 28, n_WT = 14, p = 0.718651791550678

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-all: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3359, n_rectum = 60, n_left = 133, p = 0.0791927710817998
tcga-all: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3824.5, n_rectum = 60, n_left = 133, p = 0.645961038735406
tcga-all: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4030, n_rectum = 60, n_left = 133, p = 0.912430921338582
tcga-all: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3200, n_rectum = 60, n_left = 133, p = 0.02794450463594
tcga-all: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3544, n_rectum = 60, n_left = 133, p = 0.214854656548409
tcga-all: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3620, n_rectum = 60, n_left = 133, p = 0.303605065236952
tcga-all: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3806, n_rectum = 60, n_left = 133, p = 0.667089937000163
Computing right vs left
tcga-all: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 6860, n_right = 148, n_left = 133, p = 1.16662152475699e-05
tcga-all: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 7589, n_right = 148, n_left = 133, p = 0.000926723034190986
tcga-all: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 8527, n_right = 148, n_left = 133, p = 0.0532701294114371
tcga-all: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 6378, n_right = 148, n_left = 133, p = 3.53513859137319e-07
tcga-all: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 10768, n_right = 148, n_left = 133, p = 0.173585307958795
tcga-all: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 9237, n_right = 148, n_left = 133, p = 0.374108760826281
tcga-all: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 5200, n_right = 148, n_left = 133, p = 2.2275540553044e-11

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
Computing MSS vs MSI
tcga-all: Analyzing CIRC status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 12383, n_MSS = 289, n_MSI = 53, p = 9.36844862356913e-13
tcga-all: Analyzing HIF1A status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 12219, n_MSS = 289, n_MSI = 53, p = 5.51589651452125e-12
tcga-all: Analyzing BHLHE40 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 10167, n_MSS = 289, n_MSI = 53, p = 0.000150409128584025
tcga-all: Analyzing CIITA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 12846, n_MSS = 289, n_MSI = 53, p = 4.5334700231437e-15
tcga-all: Analyzing wnt status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5071, n_MSS = 289, n_MSI = 53, p = 9.23774128755386e-05
tcga-all: Analyzing myc.sig status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8321, n_MSS = 289, n_MSI = 53, p = 0.317071268322223
tcga-all: Analyzing neoantigens status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 14555, n_MSS = 289, n_MSI = 53, p = 8.99612691829524e-26

Plotting CIRC ~ status
Plotting HIF1A ~ status
Plotting BHLHE40 ~ status
Plotting CIITA ~ status
Plotting wnt ~ status
Plotting myc.sig ~ status
Plotting neoantigens ~ status
MSI nrow =  559 
  clusters Freq
1        1  390
2        2  169
MSI clusters: 2
MSS clusters: 1
[1] -2.980897e-13
[1] -3.522599e-13
Has MSI
Has BRAF
Has CMS
Has TYMS
Has Genomic
[1] NA  2  4  6  8 10 12 NA
       [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8]
layout   NA    2    4    6    8   10   12   NA
row       1    3    5    7    9   11   13   15
[1] 1.00 5.00 0.25 0.25 0.25 0.25 1.00 2.00
[1] 1.0 2.5 2.5 2.5 2.5 0.5 1.0 0.5
     [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8]
[1,]   NA    2    4    6    8   10   12   NA
[2,]    1    3    5    7    9   11   13   15
[3,]    1    3    5    7    9   11   13   16
[4,]    1    3    5    7    9   11   13   17
[5,]    1    3    5    7    9   11   13   18
[6,]   NA   NA   NA   NA   NA   NA   NA   NA
[7,]   NA   14   NA   NA   NA   NA   NA   NA
[8,]   NA   NA   NA   NA   NA   NA   NA   NA
[1] 18
tcga-msi: Analyzing TYMS vs Imputed Status using Wilcoxon rank sum test with continuity correction: W = 54712 p = 2.44358357254431e-35 n_MSS = 390, n_MSI = 169
tcga-msi: Analyzing TYMS vs Annotated Status using Wilcoxon rank sum test with continuity correction: W = 35644 p = 8.82290348137337e-34 n_MSS = 478, n_MSI = 81
Overlap of MSI inferred and annotated in TCGA:
     
      msi mss
  msi  78   3
  mss  91 387
Number of rows analyzed: 20294
Number of columns analyzed: 344
tcga-all-msi-inferred: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-all-msi-inferred: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-all-msi-inferred: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-all-msi-inferred: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-all-msi-inferred: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-all-msi-inferred wnt vs CIRC: t = -7.66668942196379 df = 342 nrow = 344 cor = -0.3829621607261 pval = 1.84617074915233e-13
tcga-all-msi-inferred tak1 vs CIRC: t = -1.90764957903146 df = 342 nrow = 344 cor = -0.102609400758207 pval = 0.0572738736909823
tcga-all-msi-inferred wnt vs myc.sig: t = 29.5867669875905 df = 342 nrow = 344 cor = 0.847978818740452 pval = 2.60927229013165e-96
tcga-all-msi-inferred CIRC vs neoantigens: t = 7.18856145436229 df = 340 nrow = 342 cor = 0.363227593412596 pval = 4.1846192883292e-12

tcga-all-msi-inferred: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 16382, n_WT = 219, n_MT = 125, p = 0.00239184964757301
tcga-all-msi-inferred: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 14956, n_WT = 219, n_MT = 125, p = 0.152918117347929
tcga-all-msi-inferred: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12675, n_WT = 219, n_MT = 125, p = 0.253980482313371
tcga-all-msi-inferred: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15715, n_WT = 219, n_MT = 125, p = 0.0223216042395995
tcga-all-msi-inferred: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12793, n_WT = 219, n_MT = 125, p = 0.31358705965474
tcga-all-msi-inferred: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13241, n_WT = 219, n_MT = 125, p = 0.61515080317447
tcga-all-msi-inferred: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12947, n_WT = 217, n_MT = 125, p = 0.48487310568218

tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6373, n_CMS2 = 136, n_CMS1 = 51, p = 1.23959499498166e-18
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6318.5, n_CMS2 = 136, n_CMS1 = 51, p = 5.34572985361375e-18
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 4970, n_CMS2 = 136, n_CMS1 = 51, p = 5.24009718926665e-06
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6354, n_CMS2 = 136, n_CMS1 = 51, p = 2.06965323810782e-18
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1682, n_CMS2 = 136, n_CMS1 = 51, p = 6.07843507246058e-08
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 3171, n_CMS2 = 136, n_CMS1 = 51, p = 0.368407693350513
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 6531.5, n_CMS2 = 136, n_CMS1 = 51, p = 4.11558761110611e-21
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2261, n_CMS2 = 136, n_CMS3 = 42, p = 0.0416825581123066
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1448, n_CMS2 = 136, n_CMS3 = 42, p = 1.42195551760265e-06
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2038, n_CMS2 = 136, n_CMS3 = 42, p = 0.00510008881998723
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2169, n_CMS2 = 136, n_CMS3 = 42, p = 0.0186800531842814
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3902, n_CMS2 = 136, n_CMS3 = 42, p = 0.000341313512774918
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3320, n_CMS2 = 136, n_CMS3 = 42, p = 0.112311766739075
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2002.5, n_CMS2 = 136, n_CMS3 = 42, p = 0.00411497321796958
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2243, n_CMS2 = 136, n_CMS4 = 87, p = 5.51962791445972e-15
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2357, n_CMS2 = 136, n_CMS4 = 87, p = 3.67822638877412e-14
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3802, n_CMS2 = 136, n_CMS4 = 87, p = 6.88623146716682e-06
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2711, n_CMS2 = 136, n_CMS4 = 87, p = 9.19059090892192e-12
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 10043, n_CMS2 = 136, n_CMS4 = 87, p = 1.62745548681933e-18
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 9838, n_CMS2 = 136, n_CMS4 = 87, p = 7.16387570835703e-17
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5232.5, n_CMS2 = 136, n_CMS4 = 87, p = 0.217060840755576
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1136, n_CMS2 = 136, n_NOLBL = 28, p = 0.000796178954802526
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1162, n_CMS2 = 136, n_NOLBL = 28, p = 0.00119322424954628
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1564, n_CMS2 = 136, n_NOLBL = 28, p = 0.137894090993968
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1211, n_CMS2 = 136, n_NOLBL = 28, p = 0.00247521004049828
tcga-all-msi-inferred: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2377, n_CMS2 = 136, n_NOLBL = 28, p = 0.0389311268873014
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2143, n_CMS2 = 136, n_NOLBL = 28, p = 0.297277254578888
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1671, n_CMS2 = 136, n_NOLBL = 28, p = 0.336323730744777


tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 480, n_CMS2 = 41, n_CMS1 = 12, p = 2.03910940079564e-09
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 445, n_CMS2 = 41, n_CMS1 = 12, p = 3.42776539291469e-06
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 344, n_CMS2 = 41, n_CMS1 = 12, p = 0.0370659349500604
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 451, n_CMS2 = 41, n_CMS1 = 12, p = 1.32651563247495e-06
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 149, n_CMS2 = 41, n_CMS1 = 12, p = 0.0391350009745337
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 203, n_CMS2 = 41, n_CMS1 = 12, p = 0.371180469696714
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 425.5, n_CMS2 = 41, n_CMS1 = 12, p = 0.000141818624469331
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 334, n_CMS2 = 41, n_CMS3 = 28, p = 0.00300622689012917
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 250, n_CMS2 = 41, n_CMS3 = 28, p = 4.38032568801522e-05
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 448, n_CMS2 = 41, n_CMS3 = 28, p = 0.125700872851552
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 335, n_CMS2 = 41, n_CMS3 = 28, p = 0.00313513226569386
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 875, n_CMS2 = 41, n_CMS3 = 28, p = 0.000161601913359647
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 783, n_CMS2 = 41, n_CMS3 = 28, p = 0.0101843523865015
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2 = 41, n_CMS3 = 28, p = 0.0859444272951382
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 111, n_CMS2 = 41, n_CMS4 = 27, p = 1.35462358863744e-09
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 108, n_CMS2 = 41, n_CMS4 = 27, p = 9.72860092552762e-10
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 302, n_CMS2 = 41, n_CMS4 = 27, p = 0.00136443856348936
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 110, n_CMS2 = 41, n_CMS4 = 27, p = 1.2138464426316e-09
tcga-all-msi-inferred: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 986, n_CMS2 = 41, n_CMS4 = 27, p = 3.92922989387343e-09
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 1010, n_CMS2 = 41, n_CMS4 = 27, p = 2.74920522125321e-10
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2 = 41, n_CMS4 = 27, p = 0.616048341754066
tcga-all-msi-inferred: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 129, n_CMS2 = 41, n_NOLBL = 17, p = 9.27819613872329e-05
tcga-all-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 187, n_CMS2 = 41, n_NOLBL = 17, p = 0.00516746377560274
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 227, n_CMS2 = 41, n_NOLBL = 17, p = 0.0378762896354627
tcga-all-msi-inferred: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 133, n_CMS2 = 41, n_NOLBL = 17, p = 0.000128998098226766
tcga-all-msi-inferred: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 474, n_CMS2 = 41, n_NOLBL = 17, p = 0.0317913947406518
tcga-all-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 426, n_CMS2 = 41, n_NOLBL = 17, p = 0.190309804419729
tcga-all-msi-inferred: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2 = 41, n_NOLBL = 17, p = 0.0152617440877099

tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1152, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.000163233994822283
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1630, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.132770432161197
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2000, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.805223570585009
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1323, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.00308528346316024
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2204, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.224749979645318
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2218, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.2004099792463
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2098, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.414530115017996
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 12, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 2.03910940079564e-09
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 47, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 3.42776539291469e-06
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 148, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.0370659349500604
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 41, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 1.32651563247495e-06
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 343, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.0391350009745337
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 289, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.371180469696714
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 66.5, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.000141818624469331
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 42, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 5.96952388180639e-18
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 63, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 2.00739053262276e-16
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 459, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.000886489206345325
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 44, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 8.6088124778279e-18
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1337, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 4.77918260103951e-08
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 957, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.131266270713507
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS1-WT using Wilcoxon rank sum test with continuity correction: W = 44.5, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 3.78947701123408e-13
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 334, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00300622689012917
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 250, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 4.38032568801522e-05
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 448, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.125700872851552
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 335, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00313513226569386
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 875, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.000161601913359647
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 783, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0101843523865015
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0859444272951382
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 91, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 6.54057234168641e-05
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 78, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 1.62695186023443e-05
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 190, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.0617386209669866
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 114, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.000539102055503825
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 370, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.111601847559311
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 316, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.585875820946205
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 215.5, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.170032865744795
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 111, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 1.35462358863744e-09
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 108, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 9.72860092552762e-10
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 302, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.00136443856348936
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 1.2138464426316e-09
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 986, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 3.92922989387343e-09
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 1010, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 2.74920522125321e-10
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.616048341754066
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 173, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 2.74771126793874e-13
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 437, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 4.24062825237641e-08
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 877, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.0147806111464309
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 354, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 1.40844101480104e-09
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2163, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 1.12817482025658e-10
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2128, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 5.41250472810469e-10
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.844393016945285
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 129, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 9.27819613872329e-05
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 187, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.00516746377560274
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 227, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0378762896354627
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.000128998098226766
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 474, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0317913947406518
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 426, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.190309804419729
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0152617440877099
tcga-all-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 115, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0122113465867946
tcga-all-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 92, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.00205557554780918
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 257, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.492692949318259
tcga-all-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.038002252842376
tcga-all-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 301, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0931707380335296
tcga-all-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 281, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.221247642896345
tcga-all-msi-inferred: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 329, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0209489707664498

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model with interaction for neoantigens
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-all-msi-inferred: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 838, n_MT = 27, n_WT = 60, p = 0.800805944956622
tcga-all-msi-inferred: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 780, n_MT = 27, n_WT = 60, p = 0.786657472927406
tcga-all-msi-inferred: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 670, n_MT = 27, n_WT = 60, p = 0.200590727448065
tcga-all-msi-inferred: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 688, n_MT = 27, n_WT = 60, p = 0.264967936293836
tcga-all-msi-inferred: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 765, n_MT = 27, n_WT = 60, p = 0.683072479140494
tcga-all-msi-inferred: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 807, n_MT = 27, n_WT = 60, p = 0.981700729741838
tcga-all-msi-inferred: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 765, n_MT = 27, n_WT = 60, p = 0.772967967357958
tcga-all-msi-inferred: Analyzing CIRC CMS1 MT vs WT using Wilcoxon rank sum test: W = 270, n_MT = 12, n_WT = 39, p = 0.435533110162582
tcga-all-msi-inferred: Analyzing HIF1A CMS1 MT vs WT using Wilcoxon rank sum test: W = 245, n_MT = 12, n_WT = 39, p = 0.818044737273355
tcga-all-msi-inferred: Analyzing BHLHE40 CMS1 MT vs WT using Wilcoxon rank sum test: W = 225, n_MT = 12, n_WT = 39, p = 0.852268856376717
tcga-all-msi-inferred: Analyzing CIITA CMS1 MT vs WT using Wilcoxon rank sum test: W = 289, n_MT = 12, n_WT = 39, p = 0.229512386317868
tcga-all-msi-inferred: Analyzing wnt CMS1 MT vs WT using Wilcoxon rank sum test: W = 152, n_MT = 12, n_WT = 39, p = 0.0699676294093422
tcga-all-msi-inferred: Analyzing myc.sig CMS1 MT vs WT using Wilcoxon rank sum test: W = 222, n_MT = 12, n_WT = 39, p = 0.801054269531538
tcga-all-msi-inferred: Analyzing neoantigens CMS1 MT vs WT using Wilcoxon rank sum test: W = 269, n_MT = 12, n_WT = 39, p = 0.448643825148328
tcga-all-msi-inferred: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2743, n_MT = 41, n_WT = 95, p = 0.000163233994822283
tcga-all-msi-inferred: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2265, n_MT = 41, n_WT = 95, p = 0.132770432161197
tcga-all-msi-inferred: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1895, n_MT = 41, n_WT = 95, p = 0.805223570585009
tcga-all-msi-inferred: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2572, n_MT = 41, n_WT = 95, p = 0.00308528346316024
tcga-all-msi-inferred: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1691, n_MT = 41, n_WT = 95, p = 0.224749979645318
tcga-all-msi-inferred: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1677, n_MT = 41, n_WT = 95, p = 0.2004099792463
tcga-all-msi-inferred: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1756, n_MT = 41, n_WT = 95, p = 0.414530115017996
tcga-all-msi-inferred: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 84, n_MT = 17, n_WT = 11, p = 0.677092675948511
tcga-all-msi-inferred: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 112, n_MT = 17, n_WT = 11, p = 0.403501693661877
tcga-all-msi-inferred: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 46, n_MT = 17, n_WT = 11, p = 0.025216702104574
tcga-all-msi-inferred: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 17, n_WT = 11, p = 0.643498750592572
tcga-all-msi-inferred: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 17, n_WT = 11, p = 1
tcga-all-msi-inferred: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 17, n_WT = 11, p = 1
tcga-all-msi-inferred: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 24, n_MT = 17, n_WT = 11, p = 0.00116033825466856
tcga-all-msi-inferred: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 242, n_MT = 28, n_WT = 14, p = 0.227805142383617
tcga-all-msi-inferred: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 253, n_MT = 28, n_WT = 14, p = 0.132909212242862
tcga-all-msi-inferred: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 234, n_MT = 28, n_WT = 14, p = 0.321193129834995
tcga-all-msi-inferred: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 232, n_MT = 28, n_WT = 14, p = 0.347887457660636
tcga-all-msi-inferred: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 230, n_MT = 28, n_WT = 14, p = 0.375914690341709
tcga-all-msi-inferred: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 233, n_MT = 28, n_WT = 14, p = 0.334372944037949
tcga-all-msi-inferred: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 182, n_MT = 28, n_WT = 14, p = 0.718651791550678

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-all-msi-inferred: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3359, n_rectum = 60, n_left = 133, p = 0.0791927710817998
tcga-all-msi-inferred: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3824.5, n_rectum = 60, n_left = 133, p = 0.645961038735406
tcga-all-msi-inferred: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4030, n_rectum = 60, n_left = 133, p = 0.912430921338582
tcga-all-msi-inferred: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3200, n_rectum = 60, n_left = 133, p = 0.02794450463594
tcga-all-msi-inferred: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3544, n_rectum = 60, n_left = 133, p = 0.214854656548409
tcga-all-msi-inferred: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3620, n_rectum = 60, n_left = 133, p = 0.303605065236952
tcga-all-msi-inferred: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3806, n_rectum = 60, n_left = 133, p = 0.667089937000163
Computing right vs left
tcga-all-msi-inferred: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 6860, n_right = 148, n_left = 133, p = 1.16662152475699e-05
tcga-all-msi-inferred: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 7589, n_right = 148, n_left = 133, p = 0.000926723034190986
tcga-all-msi-inferred: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 8527, n_right = 148, n_left = 133, p = 0.0532701294114371
tcga-all-msi-inferred: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 6378, n_right = 148, n_left = 133, p = 3.53513859137319e-07
tcga-all-msi-inferred: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 10768, n_right = 148, n_left = 133, p = 0.173585307958795
tcga-all-msi-inferred: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 9237, n_right = 148, n_left = 133, p = 0.374108760826281
tcga-all-msi-inferred: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 5200, n_right = 148, n_left = 133, p = 2.2275540553044e-11

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
Computing MSS vs MSI
tcga-all-msi-inferred: Analyzing CIRC status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 19155, n_MSS = 238, n_MSI = 104, p = 7.70278898812392e-16
tcga-all-msi-inferred: Analyzing HIF1A status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 19862.5, n_MSS = 238, n_MSI = 104, p = 5.5864595543754e-19
tcga-all-msi-inferred: Analyzing BHLHE40 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 16849, n_MSS = 238, n_MSI = 104, p = 1.05335347016272e-07
tcga-all-msi-inferred: Analyzing CIITA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 19340, n_MSS = 238, n_MSI = 104, p = 1.24450510973477e-16
tcga-all-msi-inferred: Analyzing wnt status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 7206, n_MSS = 238, n_MSI = 104, p = 7.95009822824259e-10
tcga-all-msi-inferred: Analyzing myc.sig status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 10537, n_MSS = 238, n_MSI = 104, p = 0.028833325194037
tcga-all-msi-inferred: Analyzing neoantigens status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 19683, n_MSS = 238, n_MSI = 104, p = 1.63304627964215e-18

Plotting CIRC ~ status
Plotting HIF1A ~ status
Plotting BHLHE40 ~ status
Plotting CIITA ~ status
Plotting wnt ~ status
Plotting myc.sig ~ status
Plotting neoantigens ~ status
Number of rows analyzed: 20294
Number of columns analyzed: 238
tcga-mss-msi-inferred: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-mss-msi-inferred: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-mss-msi-inferred: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-mss-msi-inferred: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-mss-msi-inferred: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |                                                                              |=========                                                             |  12%  |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-inferred wnt vs CIRC: t = -5.83747701967491 df = 236 nrow = 238 cor = -0.355207458689606 pval = 1.74160613527648e-08
tcga-mss-msi-inferred tak1 vs CIRC: t = -1.35561728322973 df = 236 nrow = 238 cor = -0.0879015939994546 pval = 0.176516819155584
tcga-mss-msi-inferred wnt vs myc.sig: t = 26.389216502476 df = 236 nrow = 238 cor = 0.864226379603661 pval = 2.33796435878925e-72
tcga-mss-msi-inferred CIRC vs neoantigens: t = 0.846095118821313 df = 235 nrow = 237 cor = 0.055109284386355 pval = 0.398360398254445

tcga-mss-msi-inferred: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7754, n_WT = 152, n_MT = 86, p = 0.0170278702633947
tcga-mss-msi-inferred: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6706, n_WT = 152, n_MT = 86, p = 0.739743599136608
tcga-mss-msi-inferred: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5732, n_WT = 152, n_MT = 86, p = 0.115318417647796
tcga-mss-msi-inferred: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6946, n_WT = 152, n_MT = 86, p = 0.422232249365283
tcga-mss-msi-inferred: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6433, n_WT = 152, n_MT = 86, p = 0.840789578723746
tcga-mss-msi-inferred: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6254, n_WT = 152, n_MT = 86, p = 0.581157332574526
tcga-mss-msi-inferred: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5951, n_WT = 151, n_MT = 86, p = 0.285911179612945

tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 212, n_CMS2 = 135, n_CMS1 = 2, p = 0.169791567234517
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 132, n_CMS2 = 135, n_CMS1 = 2, p = 0.964214788350951
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 116, n_CMS2 = 135, n_CMS1 = 2, p = 0.739887618220606
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 180, n_CMS2 = 135, n_CMS1 = 2, p = 0.424522491256963
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 160, n_CMS2 = 135, n_CMS1 = 2, p = 0.660169937873571
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 176, n_CMS2 = 135, n_CMS1 = 2, p = 0.467338945055947
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 60.5, n_CMS2 = 135, n_CMS1 = 2, p = 0.186850848228163
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1225, n_CMS2 = 135, n_CMS3 = 17, p = 0.652611976350391
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 589, n_CMS2 = 135, n_CMS3 = 17, p = 0.00110617990879
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 891, n_CMS2 = 135, n_CMS3 = 17, p = 0.134508327828715
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 912, n_CMS2 = 135, n_CMS3 = 17, p = 0.169505831331597
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1408, n_CMS2 = 135, n_CMS3 = 17, p = 0.128525645934838
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1167, n_CMS2 = 135, n_CMS3 = 17, p = 0.911558730544977
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 831.5, n_CMS2 = 135, n_CMS3 = 17, p = 0.0706742245324048
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1850, n_CMS2 = 135, n_CMS4 = 64, p = 7.63081379233109e-11
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2138, n_CMS2 = 135, n_CMS4 = 64, p = 8.99017752315559e-09
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3080, n_CMS2 = 135, n_CMS4 = 64, p = 0.00108936081825211
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2183, n_CMS2 = 135, n_CMS4 = 64, p = 1.80030153566937e-08
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7016, n_CMS2 = 135, n_CMS4 = 64, p = 1.21842396606474e-12
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6901, n_CMS2 = 135, n_CMS4 = 64, p = 1.04463434506893e-11
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4099, n_CMS2 = 135, n_CMS4 = 64, p = 0.617130706124192
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 946, n_CMS2 = 135, n_NOLBL = 20, p = 0.0312618488535519
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 913, n_CMS2 = 135, n_NOLBL = 20, p = 0.0198133065376815
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1242, n_CMS2 = 135, n_NOLBL = 20, p = 0.566108189980937
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1026, n_CMS2 = 135, n_NOLBL = 20, p = 0.0842188139481863
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1665, n_CMS2 = 135, n_NOLBL = 20, p = 0.0932150473960216
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1457, n_CMS2 = 135, n_NOLBL = 20, p = 0.569726090004922
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1315, n_CMS2 = 135, n_NOLBL = 20, p = 0.895222240014578


tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 77, n_CMS2 = 41, n_CMS1 = 2, p = 0.026578073089701
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 41, n_CMS2 = 41, n_CMS1 = 2, p = 1
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 36, n_CMS2 = 41, n_CMS1 = 2, p = 0.799557032115172
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 62, n_CMS2 = 41, n_CMS1 = 2, p = 0.267995570321152
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 43, n_CMS2 = 41, n_CMS1 = 2, p = 0.930232558139535
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 51, n_CMS2 = 41, n_CMS1 = 2, p = 0.602436323366556
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 15.5, n_CMS2 = 41, n_CMS1 = 2, p = 0.149212343082899
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 205, n_CMS2 = 41, n_CMS3 = 11, p = 0.658477609343562
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 103, n_CMS2 = 41, n_CMS3 = 11, p = 0.00507298247781486
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 198, n_CMS2 = 41, n_CMS3 = 11, p = 0.550384524009462
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 137, n_CMS2 = 41, n_CMS3 = 11, p = 0.0476125740120781
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 300, n_CMS2 = 41, n_CMS3 = 11, p = 0.097744328129793
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 266, n_CMS2 = 41, n_CMS3 = 11, p = 0.375321129760902
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 214.5, n_CMS2 = 41, n_CMS3 = 11, p = 0.813953891301935
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 97, n_CMS2 = 41, n_CMS4 = 21, p = 7.63705467281034e-08
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 104, n_CMS2 = 41, n_CMS4 = 21, p = 1.64832546381831e-07
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 237, n_CMS2 = 41, n_CMS4 = 21, p = 0.00353343838906484
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 80, n_CMS2 = 41, n_CMS4 = 21, p = 1.00202046120147e-08
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 746, n_CMS2 = 41, n_CMS4 = 21, p = 5.15781784944858e-07
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 767, n_CMS2 = 41, n_CMS4 = 21, p = 5.4307425229687e-08
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 462, n_CMS2 = 41, n_CMS4 = 21, p = 0.644654695752475
tcga-mss-msi-inferred: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 41, n_NOLBL = 11, p = 0.00638197858647297
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 131, n_CMS2 = 41, n_NOLBL = 11, p = 0.0338325048013708
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 159, n_CMS2 = 41, n_NOLBL = 11, p = 0.140831166872711
tcga-mss-msi-inferred: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 107, n_CMS2 = 41, n_NOLBL = 11, p = 0.00687904925705246
tcga-mss-msi-inferred: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 322, n_CMS2 = 41, n_NOLBL = 11, p = 0.030048609959292
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 281, n_CMS2 = 41, n_NOLBL = 11, p = 0.221247642896345
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 152, n_CMS2 = 41, n_NOLBL = 11, p = 0.101834883487065

tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1170, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.000294928921484659
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1616, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.137362297465179
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1965, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.857599582569952
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1322, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.00382284393624789
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2184, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.219707786356691
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2199, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.193917244807792
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2085, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.390023118654653
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 5, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.026578073089701
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 41, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 1
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 46, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.799557032115172
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 20, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.267995570321152
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 39, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.930232558139535
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 31, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.602436323366556
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 66.5, n_CMS2-MT = 41, n_CMS1-MT = 2, p = 0.149212343082899
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 205, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.658477609343562
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 103, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.00507298247781486
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 198, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.550384524009462
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 137, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.0476125740120781
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.097744328129793
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 266, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.375321129760902
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 214.5, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.813953891301935
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 60, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0443100130727866
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 27, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.00099705957761591
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 77, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.150329129310692
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 57, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0343265652303365
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 156, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.308557250320906
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 122, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.987610142440941
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 65, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0667267409652141
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 97, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 7.63705467281034e-08
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 104, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 1.64832546381831e-07
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 237, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 0.00353343838906484
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 80, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 1.00202046120147e-08
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 746, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 5.15781784944858e-07
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 767, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 5.4307425229687e-08
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 462, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 0.644654695752475
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 162, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 1.3697721191633e-12
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 404, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 1.07129365846606e-05
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 725, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 0.163526850944278
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 314, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 9.91702266317277e-08
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 1488, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 8.90603150869881e-09
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 1472, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 2.47050209606039e-08
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 891, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 0.935788779099903
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 106, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.00638197858647297
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 131, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.0338325048013708
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 159, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.140831166872711
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.00687904925705246
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 322, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.030048609959292
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 281, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.221247642896345
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 152, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.101834883487065
tcga-mss-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 114, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0769057636607985
tcga-mss-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 90, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0157239634798558
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.330605767775855
tcga-mss-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.192605439130159
tcga-mss-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.330605767775855
tcga-mss-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 205, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.619257518568542
tcga-mss-msi-inferred: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 269.5, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0327771447597824

Computing linear model with interaction for CIRC
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  0.32907474 0.06635334  4.9594297 1.377301e-06
KRASMT                   KRASMT -0.02149378 0.11583589 -0.1855537 8.529590e-01
CMSCMS3                 CMSCMS3 -0.38930800 0.18962047 -2.0530905 4.120023e-02
CMSCMS2                 CMSCMS2 -0.38931702 0.08010492 -4.8600890 2.177801e-06
CMSCMS1                 CMSCMS1 -0.03385344 0.32198550 -0.1051396 9.163570e-01
CMSNOLBL               CMSNOLBL -0.25590856 0.15949359 -1.6045069 1.099806e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.22229825 0.24936304 -0.8914643 3.736158e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.30124359 0.14159633 -2.1274816 3.444920e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.16998710 0.22729761  0.7478613 4.553111e-01
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  0.29110489 0.06665718  4.3671950 1.906996e-05
KRASMT                   KRASMT  0.01756272 0.11636631  0.1509261 8.801668e-01
CMSCMS3                 CMSCMS3 -0.31989091 0.19048875 -1.6793165 9.445419e-02
CMSCMS2                 CMSCMS2 -0.35474753 0.08047172 -4.4083504 1.601731e-05
CMSCMS1                 CMSCMS1 -0.03511598 0.32345988 -0.1085636 9.136437e-01
CMSNOLBL               CMSNOLBL -0.16861118 0.16022391 -1.0523471 2.937495e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.29651899 0.25050488 -1.1836855 2.377648e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.33074135 0.14224470 -2.3251576 2.093861e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.18029682 0.22833842  0.7896035 4.305762e-01
Computing linear model with interaction for HIF1A
Could not find CMS1
                    coefficient   Estimate Std. Error     t value      Pr(>|t|)
(Intercept)         (Intercept) 10.8597556  0.1002245 108.3542490 9.695511e-199
KRASMT                   KRASMT  0.1955243  0.1749663   1.1174970  2.649529e-01
CMSCMS3                 CMSCMS3  0.2042680  0.2864155   0.7131877  4.764558e-01
CMSCMS2                 CMSCMS2 -0.4753015  0.1209958  -3.9282468  1.132997e-04
CMSCMS1                 CMSCMS1 -1.0820365  0.4863485  -2.2248171  2.706886e-02
CMSNOLBL               CMSNOLBL -0.1799748  0.2409098  -0.7470628  4.557920e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.4861083  0.3766547  -1.2905940  1.981460e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.3717075  0.2138766  -1.7379532  8.356332e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.2601954  0.3433256  -0.7578678  4.493093e-01
Could not find CMS1
                    coefficient   Estimate Std. Error     t value      Pr(>|t|)
(Intercept)         (Intercept) 10.8882266 0.09910355 109.8671686 4.299826e-200
KRASMT                   KRASMT  0.1928657 0.17300934   1.1147702  2.661175e-01
CMSCMS3                 CMSCMS3  0.2025797 0.28321199   0.7152937  4.751562e-01
CMSCMS2                 CMSCMS2 -0.5211064 0.11964253  -4.3555280  2.003219e-05
CMSCMS1                 CMSCMS1 -0.9214173 0.48090880  -1.9159917  5.661136e-02
CMSNOLBL               CMSNOLBL -0.2120526 0.23821529  -0.8901720  3.743078e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.4981954 0.37244186  -1.3376462  1.823387e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.3625030 0.21148443  -1.7140885  8.786555e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.2837601 0.33948555  -0.8358531  4.041088e-01
Computing linear model with interaction for BHLHE40
Could not find CMS1
                    coefficient   Estimate Std. Error     t value      Pr(>|t|)
(Intercept)         (Intercept) 11.6827344  0.1084515 107.7231037 3.601082e-198
KRASMT                   KRASMT  0.3186083  0.1893285   1.6828331  9.377025e-02
CMSCMS3                 CMSCMS3  0.1791794  0.3099260   0.5781360  5.637404e-01
CMSCMS2                 CMSCMS2 -0.2392360  0.1309278  -1.8272353  6.896589e-02
CMSCMS1                 CMSCMS1 -0.7415511  0.5262706  -1.4090679  1.601715e-01
CMSNOLBL               CMSNOLBL -0.5102333  0.2606850  -1.9572792  5.152959e-02
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.6371154  0.4075725  -1.5631952  1.193875e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.3122287  0.2314328  -1.3491118  1.786335e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.3431676  0.3715076   0.9237162  3.566063e-01
Could not find CMS1
                    coefficient   Estimate Std. Error     t value      Pr(>|t|)
(Intercept)         (Intercept) 11.6910503  0.1082491 108.0013133 2.017634e-198
KRASMT                   KRASMT  0.3137695  0.1889752   1.6603741  9.820783e-02
CMSCMS3                 CMSCMS3  0.1776930  0.3093477   0.5744120  5.662528e-01
CMSCMS2                 CMSCMS2 -0.2535987  0.1306835  -1.9405563  5.353961e-02
CMSCMS1                 CMSCMS1 -0.8164545  0.5252886  -1.5542970  1.214945e-01
CMSNOLBL               CMSNOLBL -0.5009573  0.2601986  -1.9252886  5.543186e-02
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.6386789  0.4068120  -1.5699607  1.178049e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -0.2996833  0.2310009  -1.2973254  1.958247e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.3311949  0.3708144   0.8931554  3.727116e-01
Computing linear model with interaction for CIITA
Could not find CMS1
                    coefficient   Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  7.2853850  0.2051923 35.5051605 4.381181e-95
KRASMT                   KRASMT  0.4015582  0.3582130  1.1210038 2.634604e-01
CMSCMS3                 CMSCMS3 -0.4259700  0.5863858 -0.7264330 4.683152e-01
CMSCMS2                 CMSCMS2 -0.8097055  0.2477179 -3.2686596 1.246781e-03
CMSCMS1                 CMSCMS1 -0.4971612  0.9957138 -0.4993013 6.180465e-01
CMSNOLBL               CMSNOLBL -0.6269067  0.4932209 -1.2710466 2.050017e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.5820706  0.7711348 -0.7548235 4.511305e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -1.1342872  0.4378751 -2.5904358 1.020057e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.1847506  0.7028993  0.2628407 7.929097e-01
Could not find CMS1
                    coefficient   Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  7.2529571  0.2057339 35.2540693 1.732731e-94
KRASMT                   KRASMT  0.4060766  0.3591585  1.1306333 2.593922e-01
CMSCMS3                 CMSCMS3 -0.3542259  0.5879336 -0.6024930 5.474422e-01
CMSCMS2                 CMSCMS2 -0.7812761  0.2483718 -3.1455915 1.877209e-03
CMSCMS1                 CMSCMS1 -0.3904657  0.9983420 -0.3911142 6.960765e-01
CMSNOLBL               CMSNOLBL -0.5407348  0.4945227 -1.0934479 2.753461e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.6257298  0.7731702 -0.8093040 4.191804e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2 -1.1174400  0.4390309 -2.5452425 1.157770e-02
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.1960529  0.7047546  0.2781861 7.811205e-01
Computing linear model with interaction for wnt
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept) -0.23742790 0.04285596 -5.5401376 8.272721e-08
KRASMT                   KRASMT -0.03886832 0.07481549 -0.5195223 6.038983e-01
CMSCMS3                 CMSCMS3  0.27620128 0.12247110  2.2552364 2.506367e-02
CMSCMS2                 CMSCMS2  0.31633208 0.05173775  6.1141442 4.147961e-09
CMSCMS1                 CMSCMS1  0.51105165 0.20796234  2.4574240 1.473644e-02
CMSNOLBL               CMSNOLBL  0.31439869 0.10301290  3.0520322 2.541339e-03
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.02774183 0.16105732 -0.1722482 8.633945e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.10509021 0.09145351  1.1491107 2.517091e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.13111042 0.14680582 -0.8930874 3.727480e-01
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept) -0.23371776 0.04332778 -5.3941781 1.713095e-07
KRASMT                   KRASMT -0.02134835 0.07563917 -0.2822394 7.780149e-01
CMSCMS3                 CMSCMS3  0.32123425 0.12381944  2.5943764 1.008774e-02
CMSCMS2                 CMSCMS2  0.30031157 0.05230736  5.7412872 2.966586e-08
CMSCMS1                 CMSCMS1  0.43151922 0.21025190  2.0523915 4.126868e-02
CMSNOLBL               CMSNOLBL  0.28252887 0.10414702  2.7127888 7.178747e-03
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.09224150 0.16283048 -0.5664879 5.716169e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.11019523 0.09246037  1.1918104 2.345693e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.10346228 0.14842208 -0.6970815 4.864589e-01
Computing linear model with interaction for myc.sig
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept) -0.24001790 0.04526122 -5.3029484 2.681040e-07
KRASMT                   KRASMT -0.05441739 0.07901446 -0.6887017 4.917081e-01
CMSCMS3                 CMSCMS3  0.38105298 0.12934470  2.9460270 3.551218e-03
CMSCMS2                 CMSCMS2  0.30100094 0.05464150  5.5086511 9.690631e-08
CMSCMS1                 CMSCMS1  0.55630361 0.21963408  2.5328656 1.198274e-02
CMSNOLBL               CMSNOLBL  0.34537251 0.10879443  3.1745423 1.706798e-03
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.05737610 0.17009655 -0.3373149 7.361885e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.14367685 0.09658627  1.4875494 1.382454e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.06728238 0.15504519 -0.4339534 6.647309e-01
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept) -0.24411240 0.04529441 -5.3894598 1.753477e-07
KRASMT                   KRASMT -0.03655210 0.07907240 -0.4622611 6.443330e-01
CMSCMS3                 CMSCMS3  0.37718709 0.12943955  2.9140017 3.921889e-03
CMSCMS2                 CMSCMS2  0.29958677 0.05468157  5.4787525 1.125469e-07
CMSCMS1                 CMSCMS1  0.50869939 0.21979515  2.3144250 2.153029e-02
CMSNOLBL               CMSNOLBL  0.33013380 0.10887421  3.0322498 2.706964e-03
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.05966510 0.17022129 -0.3505149 7.262745e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.14356929 0.09665710  1.4853464 1.388274e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL -0.05598425 0.15515889 -0.3608188 7.185675e-01
Computing linear model with interaction for neoantigens
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  1.74190665 0.04779378 36.4463028 4.586227e-97
KRASMT                   KRASMT -0.02772657 0.08343567 -0.3323108 7.399599e-01
CMSCMS3                 CMSCMS3  0.20946903 0.13658211  1.5336491 1.265024e-01
CMSCMS2                 CMSCMS2 -0.04152363 0.05779621 -0.7184489 4.732161e-01
CMSCMS1                 CMSCMS1 -0.20234812 0.23192358 -0.8724776 3.838658e-01
CMSNOLBL               CMSNOLBL -0.06699858 0.11488195 -0.5831950 5.603384e-01
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.09821633 0.17961420 -0.5468183 5.850383e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.06559151 0.10204577  0.6427656 5.210220e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.24449186 0.16372065  1.4933477 1.367287e-01
Could not find CMS1
                    coefficient    Estimate Std. Error    t value     Pr(>|t|)
(Intercept)         (Intercept)  1.74839588 0.04717164 37.0645520 1.719257e-98
KRASMT                   KRASMT -0.03326432 0.08234957 -0.4039404 6.866352e-01
CMSCMS3                 CMSCMS3  0.24346991 0.13480420  1.8061003 7.222140e-02
CMSCMS2                 CMSCMS2 -0.04520132 0.05704387 -0.7923957 4.289537e-01
CMSCMS1                 CMSCMS1 -0.24992467 0.22890460 -1.0918289 2.760607e-01
CMSNOLBL               CMSNOLBL -0.21515105 0.11338652 -1.8975011 5.902532e-02
KRASMT:CMSCMS3   KRASMT:CMSCMS3 -0.15087800 0.17727614 -0.8510903 3.956122e-01
KRASMT:CMSCMS2   KRASMT:CMSCMS2  0.08021974 0.10071743  0.7964832 4.265798e-01
KRASMT:CMSNOLBL KRASMT:CMSNOLBL  0.41638448 0.16158948  2.5768044 1.060241e-02
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-mss-msi-inferred: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test: W = 435, n_MT = 21, n_WT = 43, p = 0.820503139725541
tcga-mss-msi-inferred: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test: W = 390, n_MT = 21, n_WT = 43, p = 0.386090876113363
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test: W = 313, n_MT = 21, n_WT = 43, p = 0.047895153078855
tcga-mss-msi-inferred: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test: W = 335, n_MT = 21, n_WT = 43, p = 0.0974311602090096
tcga-mss-msi-inferred: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test: W = 485, n_MT = 21, n_WT = 43, p = 0.639645708717878
tcga-mss-msi-inferred: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test: W = 488, n_MT = 21, n_WT = 43, p = 0.609479650061574
tcga-mss-msi-inferred: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 486, n_MT = 21, n_WT = 43, p = 0.626782922983445
tcga-mss-msi-inferred: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2684, n_MT = 41, n_WT = 94, p = 0.000294928921484659
tcga-mss-msi-inferred: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2238, n_MT = 41, n_WT = 94, p = 0.137362297465179
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1889, n_MT = 41, n_WT = 94, p = 0.857599582569952
tcga-mss-msi-inferred: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2532, n_MT = 41, n_WT = 94, p = 0.00382284393624789
tcga-mss-msi-inferred: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1670, n_MT = 41, n_WT = 94, p = 0.219707786356691
tcga-mss-msi-inferred: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1655, n_MT = 41, n_WT = 94, p = 0.193917244807792
tcga-mss-msi-inferred: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1728, n_MT = 41, n_WT = 94, p = 0.390023118654653
tcga-mss-msi-inferred: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 40, n_MT = 11, n_WT = 9, p = 0.502726839723744
tcga-mss-msi-inferred: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 11, n_WT = 9, p = 0.655632293403191
tcga-mss-msi-inferred: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 22, n_MT = 11, n_WT = 9, p = 0.0381281257442248
tcga-mss-msi-inferred: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 9, p = 0.411895689449869
tcga-mss-msi-inferred: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 11, n_WT = 9, p = 0.331162181471779
tcga-mss-msi-inferred: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 11, n_WT = 9, p = 0.655632293403191
tcga-mss-msi-inferred: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 14.5, n_MT = 11, n_WT = 9, p = 0.00868899086167893
tcga-mss-msi-inferred: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 47, n_MT = 11, n_WT = 6, p = 0.180187459599224
tcga-mss-msi-inferred: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 45, n_MT = 11, n_WT = 6, p = 0.256140917905624
tcga-mss-msi-inferred: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 43, n_MT = 11, n_WT = 6, p = 0.350193923723336
tcga-mss-msi-inferred: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 37, n_MT = 11, n_WT = 6, p = 0.732546864899806
tcga-mss-msi-inferred: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 6, p = 0.660471881060116
tcga-mss-msi-inferred: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 6, p = 0.660471881060116
tcga-mss-msi-inferred: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 47.5, n_MT = 11, n_WT = 6, p = 0.15915597452002

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-mss-msi-inferred: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2210, n_rectum = 43, n_left = 118, p = 0.212213677498416
tcga-mss-msi-inferred: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2451, n_rectum = 43, n_left = 118, p = 0.743909102466494
tcga-mss-msi-inferred: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2783, n_rectum = 43, n_left = 118, p = 0.348237148383624
tcga-mss-msi-inferred: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2243, n_rectum = 43, n_left = 118, p = 0.262111661753397
tcga-mss-msi-inferred: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1970, n_rectum = 43, n_left = 118, p = 0.030425916983339
tcga-mss-msi-inferred: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2129, n_rectum = 43, n_left = 118, p = 0.119473137030984
tcga-mss-msi-inferred: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2746, n_rectum = 43, n_left = 118, p = 0.425577654191663
Computing right vs left
tcga-mss-msi-inferred: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 4102, n_right = 75, n_left = 118, p = 0.393878425381178
tcga-mss-msi-inferred: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 4419, n_right = 75, n_left = 118, p = 0.988398729041423
tcga-mss-msi-inferred: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 4477, n_right = 75, n_left = 118, p = 0.891700791425639
tcga-mss-msi-inferred: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 4010, n_right = 75, n_left = 118, p = 0.27315376046122
tcga-mss-msi-inferred: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 3995, n_right = 75, n_left = 118, p = 0.256172284353521
tcga-mss-msi-inferred: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 3891, n_right = 75, n_left = 118, p = 0.158411784720041
tcga-mss-msi-inferred: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 3488.5, n_right = 75, n_left = 118, p = 0.0192595772067348

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
Overlap of MSI and CMS1 in TCGA inferred:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   74    1   42   33    19
  mss    2  214   27  105    42
Number of rows analyzed: 20294
Number of columns analyzed: 236
tcga-mss-msi-inferred-no-cms: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-mss-msi-inferred-no-cms: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-mss-msi-inferred-no-cms: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-mss-msi-inferred-no-cms: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-mss-msi-inferred-no-cms: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-inferred-no-cms wnt vs CIRC: t = -5.99572844367793 df = 234 nrow = 236 cor = -0.36492304210627 pval = 7.61645165191764e-09
tcga-mss-msi-inferred-no-cms tak1 vs CIRC: t = -1.30864013913241 df = 234 nrow = 236 cor = -0.0852371448735814 pval = 0.191940089260213
tcga-mss-msi-inferred-no-cms wnt vs myc.sig: t = 26.3697867532818 df = 234 nrow = 236 cor = 0.864994425534086 pval = 5.00793553620202e-72
tcga-mss-msi-inferred-no-cms CIRC vs neoantigens: t = 0.893424063149842 df = 233 nrow = 235 cor = 0.0584301576010288 pval = 0.372551978295441

tcga-mss-msi-inferred-no-cms: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7633, n_WT = 152, n_MT = 84, p = 0.0129099807400285
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6538, n_WT = 152, n_MT = 84, p = 0.759850249075497
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5553, n_WT = 152, n_MT = 84, p = 0.0981591298865082
tcga-mss-msi-inferred-no-cms: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6817, n_WT = 152, n_MT = 84, p = 0.389087383685068
tcga-mss-msi-inferred-no-cms: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6346, n_WT = 152, n_MT = 84, p = 0.940471787527196
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 6172, n_WT = 152, n_MT = 84, p = 0.673625315540299
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5713.5, n_WT = 151, n_MT = 84, p = 0.208559146600745

tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1223, n_CMS2 = 135, n_CMS3 = 17, p = 0.661063948089389
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 589, n_CMS2 = 135, n_CMS3 = 17, p = 0.00110617990879
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 891, n_CMS2 = 135, n_CMS3 = 17, p = 0.134508327828715
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 912, n_CMS2 = 135, n_CMS3 = 17, p = 0.169505831331597
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1404, n_CMS2 = 135, n_CMS3 = 17, p = 0.134508327828715
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1167, n_CMS2 = 135, n_CMS3 = 17, p = 0.911558730544977
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 831.5, n_CMS2 = 135, n_CMS3 = 17, p = 0.0706742245324048
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1846, n_CMS2 = 135, n_CMS4 = 64, p = 7.11348210424442e-11
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2138, n_CMS2 = 135, n_CMS4 = 64, p = 8.99017752315559e-09
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3080, n_CMS2 = 135, n_CMS4 = 64, p = 0.00108936081825211
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2183, n_CMS2 = 135, n_CMS4 = 64, p = 1.80030153566937e-08
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7023, n_CMS2 = 135, n_CMS4 = 64, p = 1.06593985779953e-12
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6900, n_CMS2 = 135, n_CMS4 = 64, p = 1.06391551070951e-11
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4099, n_CMS2 = 135, n_CMS4 = 64, p = 0.617130706124192
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 946, n_CMS2 = 135, n_NOLBL = 20, p = 0.0312618488535519
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 913, n_CMS2 = 135, n_NOLBL = 20, p = 0.0198133065376815
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1242, n_CMS2 = 135, n_NOLBL = 20, p = 0.566108189980937
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1026, n_CMS2 = 135, n_NOLBL = 20, p = 0.0842188139481863
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1666, n_CMS2 = 135, n_NOLBL = 20, p = 0.0921788824433835
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1463, n_CMS2 = 135, n_NOLBL = 20, p = 0.548186001677705
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1315, n_CMS2 = 135, n_NOLBL = 20, p = 0.895222240014578


tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 207, n_CMS2 = 41, n_CMS3 = 11, p = 0.69081929336732
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 103, n_CMS2 = 41, n_CMS3 = 11, p = 0.00507298247781486
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 198, n_CMS2 = 41, n_CMS3 = 11, p = 0.550384524009462
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 137, n_CMS2 = 41, n_CMS3 = 11, p = 0.0476125740120781
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 299, n_CMS2 = 41, n_CMS3 = 11, p = 0.102489874232738
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 267, n_CMS2 = 41, n_CMS3 = 11, p = 0.363408106677409
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 214.5, n_CMS2 = 41, n_CMS3 = 11, p = 0.813953891301935
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 97, n_CMS2 = 41, n_CMS4 = 21, p = 7.63705467281034e-08
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 104, n_CMS2 = 41, n_CMS4 = 21, p = 1.64832546381831e-07
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 237, n_CMS2 = 41, n_CMS4 = 21, p = 0.00353343838906484
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 80, n_CMS2 = 41, n_CMS4 = 21, p = 1.00202046120147e-08
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 747, n_CMS2 = 41, n_CMS4 = 21, p = 4.66477224074526e-07
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 769, n_CMS2 = 41, n_CMS4 = 21, p = 4.30962301603806e-08
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 462, n_CMS2 = 41, n_CMS4 = 21, p = 0.644654695752475
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 41, n_NOLBL = 11, p = 0.00638197858647297
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 131, n_CMS2 = 41, n_NOLBL = 11, p = 0.0338325048013708
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 159, n_CMS2 = 41, n_NOLBL = 11, p = 0.140831166872711
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 107, n_CMS2 = 41, n_NOLBL = 11, p = 0.00687904925705246
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 322, n_CMS2 = 41, n_NOLBL = 11, p = 0.030048609959292
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 282, n_CMS2 = 41, n_NOLBL = 11, p = 0.212839182926178
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 152, n_CMS2 = 41, n_NOLBL = 11, p = 0.101834883487065

tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1174, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.000317514664054919
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1616, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.137362297465179
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1965, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.857599582569952
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1322, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.00382284393624789
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2184, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.219707786356691
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2196, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.198888989985768
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2085, n_CMS2-MT = 41, n_CMS2-WT = 94, p = 0.390023118654653
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 207, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.69081929336732
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 103, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.00507298247781486
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 198, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.550384524009462
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 137, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.0476125740120781
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 299, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.102489874232738
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 267, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.363408106677409
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 214.5, n_CMS2-MT = 41, n_CMS3-MT = 11, p = 0.813953891301935
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 60, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0443100130727866
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 27, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.00099705957761591
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 77, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.150329129310692
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 57, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0343265652303365
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 155, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.323945085169619
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 122, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.987610142440941
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 65, n_CMS2-MT = 41, n_CMS3-WT = 6, p = 0.0667267409652141
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 97, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 7.63705467281034e-08
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 104, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 1.64832546381831e-07
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 237, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 0.00353343838906484
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 80, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 1.00202046120147e-08
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 747, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 4.66477224074526e-07
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 769, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 4.30962301603806e-08
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 462, n_CMS2-MT = 41, n_CMS4-MT = 21, p = 0.644654695752475
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 164, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 1.64883998075595e-12
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 404, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 1.07129365846606e-05
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 725, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 0.163526850944278
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 314, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 9.91702266317277e-08
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 1490, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 7.81423651798596e-09
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 1471, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 2.62923519945471e-08
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 891, n_CMS2-MT = 41, n_CMS4-WT = 43, p = 0.935788779099903
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 106, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.00638197858647297
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 131, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.0338325048013708
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 159, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.140831166872711
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.00687904925705246
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 322, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.030048609959292
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 282, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.212839182926178
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 152, n_CMS2-MT = 41, n_NOLBL-MT = 11, p = 0.101834883487065
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 115, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0813873542133643
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 90, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0157239634798558
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.330605767775855
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.192605439130159
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 225, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.318216551489668
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 207, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.584545565105156
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 269.5, n_CMS2-MT = 41, n_NOLBL-WT = 9, p = 0.0327771447597824

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model with interaction for neoantigens
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test: W = 435, n_MT = 21, n_WT = 43, p = 0.820503139725541
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test: W = 390, n_MT = 21, n_WT = 43, p = 0.386090876113363
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test: W = 313, n_MT = 21, n_WT = 43, p = 0.047895153078855
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test: W = 335, n_MT = 21, n_WT = 43, p = 0.0974311602090096
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test: W = 484, n_MT = 21, n_WT = 43, p = 0.649835993865151
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test: W = 486, n_MT = 21, n_WT = 43, p = 0.629521849163063
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 486, n_MT = 21, n_WT = 43, p = 0.626782922983445
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2680, n_MT = 41, n_WT = 94, p = 0.000317514664054919
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2238, n_MT = 41, n_WT = 94, p = 0.137362297465179
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1889, n_MT = 41, n_WT = 94, p = 0.857599582569952
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2532, n_MT = 41, n_WT = 94, p = 0.00382284393624789
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1670, n_MT = 41, n_WT = 94, p = 0.219707786356691
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1658, n_MT = 41, n_WT = 94, p = 0.198888989985768
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1728, n_MT = 41, n_WT = 94, p = 0.390023118654653
tcga-mss-msi-inferred-no-cms: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 40, n_MT = 11, n_WT = 9, p = 0.502726839723744
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 11, n_WT = 9, p = 0.655632293403191
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 22, n_MT = 11, n_WT = 9, p = 0.0381281257442248
tcga-mss-msi-inferred-no-cms: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 9, p = 0.411895689449869
tcga-mss-msi-inferred-no-cms: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 11, n_WT = 9, p = 0.331162181471779
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 11, n_WT = 9, p = 0.655632293403191
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 14.5, n_MT = 11, n_WT = 9, p = 0.00868899086167893
tcga-mss-msi-inferred-no-cms: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 47, n_MT = 11, n_WT = 6, p = 0.180187459599224
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 45, n_MT = 11, n_WT = 6, p = 0.256140917905624
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 43, n_MT = 11, n_WT = 6, p = 0.350193923723336
tcga-mss-msi-inferred-no-cms: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 37, n_MT = 11, n_WT = 6, p = 0.732546864899806
tcga-mss-msi-inferred-no-cms: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 6, p = 0.660471881060116
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 38, n_MT = 11, n_WT = 6, p = 0.660471881060116
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 47.5, n_MT = 11, n_WT = 6, p = 0.15915597452002

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-mss-msi-inferred-no-cms: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2215, n_rectum = 43, n_left = 118, p = 0.21929785206683
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2451, n_rectum = 43, n_left = 118, p = 0.743909102466494
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2783, n_rectum = 43, n_left = 118, p = 0.348237148383624
tcga-mss-msi-inferred-no-cms: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2243, n_rectum = 43, n_left = 118, p = 0.262111661753397
tcga-mss-msi-inferred-no-cms: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1966, n_rectum = 43, n_left = 118, p = 0.0292734494744372
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2122, n_rectum = 43, n_left = 118, p = 0.113254115674362
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2746, n_rectum = 43, n_left = 118, p = 0.425577654191663
Computing right vs left
tcga-mss-msi-inferred-no-cms: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 4039, n_right = 73, n_left = 118, p = 0.471189245752711
tcga-mss-msi-inferred-no-cms: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 4290, n_right = 73, n_left = 118, p = 0.964549805752483
tcga-mss-msi-inferred-no-cms: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 4340, n_right = 73, n_left = 118, p = 0.930239985956267
tcga-mss-msi-inferred-no-cms: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 3917, n_right = 73, n_left = 118, p = 0.294100802630554
tcga-mss-msi-inferred-no-cms: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 3943, n_right = 73, n_left = 118, p = 0.327513931537614
tcga-mss-msi-inferred-no-cms: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 3839, n_right = 73, n_left = 118, p = 0.207932476602811
tcga-mss-msi-inferred-no-cms: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 3308, n_right = 73, n_left = 118, p = 0.0106151455194015

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
Number of rows analyzed: 20294
Number of columns analyzed: 289
tcga-mss-msi-annotated: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-mss-msi-annotated: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-mss-msi-annotated: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-mss-msi-annotated: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-mss-msi-annotated: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-annotated wnt vs CIRC: t = -6.48169351043605 df = 287 nrow = 289 cor = -0.357340623456176 pval = 3.94381010590036e-10
tcga-mss-msi-annotated tak1 vs CIRC: t = -1.28667906107693 df = 287 nrow = 289 cor = -0.0757321493474332 pval = 0.199243045098411
tcga-mss-msi-annotated wnt vs myc.sig: t = 32.495758885224 df = 287 nrow = 289 cor = 0.886732906569273 pval = 3.57071642866538e-98
tcga-mss-msi-annotated CIRC vs neoantigens: t = 2.39524348590726 df = 286 nrow = 288 cor = 0.140234144348784 pval = 0.0172525425226077

tcga-mss-msi-annotated: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11491, n_WT = 178, n_MT = 111, p = 0.0196945062875836
tcga-mss-msi-annotated: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10372, n_WT = 178, n_MT = 111, p = 0.476011444053582
tcga-mss-msi-annotated: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8879, n_WT = 178, n_MT = 111, p = 0.14805148745672
tcga-mss-msi-annotated: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10796, n_WT = 178, n_MT = 111, p = 0.184729392864197
tcga-mss-msi-annotated: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9589, n_WT = 178, n_MT = 111, p = 0.675248086819904
tcga-mss-msi-annotated: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9412, n_WT = 178, n_MT = 111, p = 0.499608605777798
tcga-mss-msi-annotated: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8459, n_WT = 177, n_MT = 111, p = 0.0473545964186358

tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1194, n_CMS2 = 134, n_CMS1 = 11, p = 0.000652404484588809
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1118.5, n_CMS2 = 134, n_CMS1 = 11, p = 0.00444035817594463
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1001, n_CMS2 = 134, n_CMS1 = 11, p = 0.0491092494893311
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1212, n_CMS2 = 134, n_CMS1 = 11, p = 0.000395229377171277
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 640, n_CMS2 = 134, n_CMS1 = 11, p = 0.471157176472037
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 659, n_CMS2 = 134, n_CMS1 = 11, p = 0.562779319742071
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1120.5, n_CMS2 = 134, n_CMS1 = 11, p = 0.00347364973534146
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1896, n_CMS2 = 134, n_CMS3 = 35, p = 0.0818639847645432
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1139, n_CMS2 = 134, n_CMS3 = 35, p = 2.91414375496482e-06
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1751, n_CMS2 = 134, n_CMS3 = 35, p = 0.0213067449272818
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1828, n_CMS2 = 134, n_CMS3 = 35, p = 0.0450936176798174
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3281, n_CMS2 = 134, n_CMS3 = 35, p = 0.00028418470597493
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2897, n_CMS2 = 134, n_CMS3 = 35, p = 0.0323900281988977
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1980.5, n_CMS2 = 134, n_CMS3 = 35, p = 0.175905507483851
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2107, n_CMS2 = 134, n_CMS4 = 81, p = 5.91150645874666e-14
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2278, n_CMS2 = 134, n_CMS4 = 81, p = 1.05482298006014e-12
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3507, n_CMS2 = 134, n_CMS4 = 81, p = 1.40760675674535e-05
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2561, n_CMS2 = 134, n_CMS4 = 81, p = 8.99767699074349e-11
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 9120, n_CMS2 = 134, n_CMS4 = 81, p = 6.60445069877618e-17
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8946, n_CMS2 = 134, n_CMS4 = 81, p = 1.71699989545954e-15
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5168, n_CMS2 = 134, n_CMS4 = 81, p = 0.619702397780442
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1125, n_CMS2 = 134, n_NOLBL = 28, p = 0.000886021239762394
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1155, n_CMS2 = 134, n_NOLBL = 28, p = 0.00141519757159751
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1543, n_CMS2 = 134, n_NOLBL = 28, p = 0.140792825305331
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1186, n_CMS2 = 134, n_NOLBL = 28, p = 0.00225649927773907
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2356, n_CMS2 = 134, n_NOLBL = 28, p = 0.0336703459806017
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2121, n_CMS2 = 134, n_NOLBL = 28, p = 0.278790920460274
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1653.5, n_CMS2 = 134, n_NOLBL = 28, p = 0.353519620989398


tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 195, n_CMS2 = 41, n_CMS1 = 5, p = 0.000164872763457192
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 162, n_CMS2 = 41, n_CMS1 = 5, p = 0.0343285520231931
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 135, n_CMS2 = 41, n_CMS1 = 5, p = 0.26780735274163
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 166, n_CMS2 = 41, n_CMS1 = 5, p = 0.0227480642040804
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 91, n_CMS2 = 41, n_CMS1 = 5, p = 0.70640100265985
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 81, n_CMS2 = 41, n_CMS1 = 5, p = 0.470206908022884
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 138.5, n_CMS2 = 41, n_CMS1 = 5, p = 0.210125907077532
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 284, n_CMS2 = 41, n_CMS3 = 23, p = 0.00817148291138145
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 212, n_CMS2 = 41, n_CMS3 = 23, p = 0.000187331428762152
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 414, n_CMS2 = 41, n_CMS3 = 23, p = 0.428041291929672
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 289, n_CMS2 = 41, n_CMS3 = 23, p = 0.0101263134924805
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 710, n_CMS2 = 41, n_CMS3 = 23, p = 0.000649803667440001
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 659, n_CMS2 = 41, n_CMS3 = 23, p = 0.00817148291138145
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2 = 41, n_CMS3 = 23, p = 0.594862093429313
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 114, n_CMS2 = 41, n_CMS4 = 25, p = 1.10719811001573e-08
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 107, n_CMS2 = 41, n_CMS4 = 25, p = 5.19835180940529e-09
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 267, n_CMS2 = 41, n_CMS4 = 25, p = 0.0009484735671893
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 110, n_CMS2 = 41, n_CMS4 = 25, p = 7.21468388832661e-09
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 908, n_CMS2 = 41, n_CMS4 = 25, p = 1.51700332865419e-08
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 927, n_CMS2 = 41, n_CMS4 = 25, p = 1.87610296772545e-09
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2 = 41, n_CMS4 = 25, p = 1
tcga-mss-msi-annotated: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 126, n_CMS2 = 41, n_NOLBL = 17, p = 7.20358840030812e-05
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 187, n_CMS2 = 41, n_NOLBL = 17, p = 0.00516746377560274
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 227, n_CMS2 = 41, n_NOLBL = 17, p = 0.0378762896354627
tcga-mss-msi-annotated: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 133, n_CMS2 = 41, n_NOLBL = 17, p = 0.000128998098226766
tcga-mss-msi-annotated: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 474, n_CMS2 = 41, n_NOLBL = 17, p = 0.0317913947406518
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 423, n_CMS2 = 41, n_NOLBL = 17, p = 0.208362859333137
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2 = 41, n_NOLBL = 17, p = 0.0152617440877099

tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1157, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.000298770014942816
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1577, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.112174135151795
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1959, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.801760500465988
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1300, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.00343435427649365
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2144, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.252500571360156
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2162, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.218246047020678
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2044.5, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.441306704341132
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 10, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.000164872763457192
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 43, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.0343285520231931
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 70, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.26780735274163
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 39, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.0227480642040804
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 114, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.70640100265985
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 124, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.470206908022884
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 66.5, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.210125907077532
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 30, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.00159197986360605
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 37, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.00417729406822193
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 76, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.141236758064415
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 5, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 3.53897477577102e-06
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 158, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.279176122946964
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 150, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.407808356692895
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS1-WT using Wilcoxon rank sum test with continuity correction: W = 44.5, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.0128728270353521
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 284, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.00817148291138145
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 212, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000187331428762152
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 414, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.428041291929672
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 289, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0101263134924805
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 710, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000649803667440001
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 659, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.00817148291138145
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.594862093429313
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 80, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.000209402696505999
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 50, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 5.35075800875105e-06
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 148, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0370659349500604
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 101, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.00148802097607671
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 343, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0391350009745337
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 306, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.208986563515792
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 215.5, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.523657178039454
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 114, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1.10719811001573e-08
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 5.19835180940529e-09
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 267, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.0009484735671893
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 7.21468388832661e-09
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 908, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1.51700332865419e-08
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 927, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1.87610296772545e-09
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 168, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 8.48215538892192e-13
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 423, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.21712016204261e-07
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 841, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.0252002126232531
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 338, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 3.38703711312013e-09
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2002, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 4.57668300652255e-10
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1975, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.58181688235684e-09
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.812344687460441
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 126, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 7.20358840030812e-05
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 187, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.00516746377560274
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 227, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0378762896354627
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.000128998098226766
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 474, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0317913947406518
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 423, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.208362859333137
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0152617440877099
tcga-mss-msi-annotated: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 121, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0182426116923811
tcga-mss-msi-annotated: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 92, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.00205557554780918
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 257, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.492692949318259
tcga-mss-msi-annotated: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.038002252842376
tcga-mss-msi-annotated: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 301, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0931707380335296
tcga-mss-msi-annotated: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 279, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.238750874506442
tcga-mss-msi-annotated: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 329, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0209489707664498

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model with interaction for neoantigens
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-mss-msi-annotated: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 771, n_MT = 25, n_WT = 56, p = 0.471038684776457
tcga-mss-msi-annotated: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 687, n_MT = 25, n_WT = 56, p = 0.898307520633756
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 547, n_MT = 25, n_WT = 56, p = 0.118959502513599
tcga-mss-msi-annotated: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 610, n_MT = 25, n_WT = 56, p = 0.360167716906832
tcga-mss-msi-annotated: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 670, n_MT = 25, n_WT = 56, p = 0.762951523885058
tcga-mss-msi-annotated: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 708, n_MT = 25, n_WT = 56, p = 0.9388782785685
tcga-mss-msi-annotated: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 683, n_MT = 25, n_WT = 56, p = 0.866016636827914
tcga-mss-msi-annotated: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2656, n_MT = 41, n_WT = 93, p = 0.000298770014942816
tcga-mss-msi-annotated: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2236, n_MT = 41, n_WT = 93, p = 0.112174135151795
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1854, n_MT = 41, n_WT = 93, p = 0.801760500465988
tcga-mss-msi-annotated: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2513, n_MT = 41, n_WT = 93, p = 0.00343435427649365
tcga-mss-msi-annotated: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1669, n_MT = 41, n_WT = 93, p = 0.252500571360156
tcga-mss-msi-annotated: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1651, n_MT = 41, n_WT = 93, p = 0.218246047020678
tcga-mss-msi-annotated: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1727.5, n_MT = 41, n_WT = 93, p = 0.441306704341132
tcga-mss-msi-annotated: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 81, n_MT = 17, n_WT = 11, p = 0.578432051887429
tcga-mss-msi-annotated: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 112, n_MT = 17, n_WT = 11, p = 0.403501693661877
tcga-mss-msi-annotated: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 46, n_MT = 17, n_WT = 11, p = 0.025216702104574
tcga-mss-msi-annotated: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 17, n_WT = 11, p = 0.643498750592572
tcga-mss-msi-annotated: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 95, n_MT = 17, n_WT = 11, p = 0.963130885556515
tcga-mss-msi-annotated: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 95, n_MT = 17, n_WT = 11, p = 0.963130885556515
tcga-mss-msi-annotated: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 24, n_MT = 17, n_WT = 11, p = 0.00116033825466856
tcga-mss-msi-annotated: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 169, n_MT = 23, n_WT = 12, p = 0.29378493041779
tcga-mss-msi-annotated: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 197, n_MT = 23, n_WT = 12, p = 0.0408102349350795
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 189, n_MT = 23, n_WT = 12, p = 0.0791312236368835
tcga-mss-msi-annotated: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 23, n_WT = 12, p = 0.460505855461035
tcga-mss-msi-annotated: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 147, n_MT = 23, n_WT = 12, p = 0.770966011458062
tcga-mss-msi-annotated: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 151, n_MT = 23, n_WT = 12, p = 0.668423000585534
tcga-mss-msi-annotated: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 139, n_MT = 23, n_WT = 12, p = 0.986132610427574
tcga-mss-msi-annotated: Analyzing CIRC CMS1 MT vs WT using Wilcoxon rank sum test: W = 14, n_MT = 5, n_WT = 6, p = 0.930735930735931
tcga-mss-msi-annotated: Analyzing HIF1A CMS1 MT vs WT using Wilcoxon rank sum test: W = 13, n_MT = 5, n_WT = 6, p = 0.792207792207792
tcga-mss-msi-annotated: Analyzing BHLHE40 CMS1 MT vs WT using Wilcoxon rank sum test: W = 14, n_MT = 5, n_WT = 6, p = 0.930735930735931
tcga-mss-msi-annotated: Analyzing CIITA CMS1 MT vs WT using Wilcoxon rank sum test: W = 19, n_MT = 5, n_WT = 6, p = 0.536796536796537
tcga-mss-msi-annotated: Analyzing wnt CMS1 MT vs WT using Wilcoxon rank sum test: W = 12, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing myc.sig CMS1 MT vs WT using Wilcoxon rank sum test: W = 12, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing neoantigens CMS1 MT vs WT using Wilcoxon rank sum test: W = 21, n_MT = 5, n_WT = 6, p = 0.329004329004329

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-mss-msi-annotated: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3071, n_rectum = 58, n_left = 126, p = 0.082668688559254
tcga-mss-msi-annotated: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3482.5, n_rectum = 58, n_left = 126, p = 0.610436637581097
tcga-mss-msi-annotated: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3642, n_rectum = 58, n_left = 126, p = 0.972668816812418
tcga-mss-msi-annotated: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2953, n_rectum = 58, n_left = 126, p = 0.0368919659677559
tcga-mss-msi-annotated: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3233, n_rectum = 58, n_left = 126, p = 0.210289270428802
tcga-mss-msi-annotated: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3248, n_rectum = 58, n_left = 126, p = 0.227015792756712
tcga-mss-msi-annotated: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3489, n_rectum = 58, n_left = 126, p = 0.62402181659268
Computing right vs left
tcga-mss-msi-annotated: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 5611, n_right = 103, n_left = 126, p = 0.0785059080274324
tcga-mss-msi-annotated: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 6030, n_right = 103, n_left = 126, p = 0.357933254141967
tcga-mss-msi-annotated: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6125, n_right = 103, n_left = 126, p = 0.466104636945474
tcga-mss-msi-annotated: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 5400, n_right = 103, n_left = 126, p = 0.0290737623211798
tcga-mss-msi-annotated: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 6319, n_right = 103, n_left = 126, p = 0.733966398878356
tcga-mss-msi-annotated: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 6197, n_right = 103, n_left = 126, p = 0.55890490832787
tcga-mss-msi-annotated: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 4522, n_right = 103, n_left = 126, p = 0.000121071371193007

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
Overlap of MSI and CMS1 in TCGA annotated:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   62    1   11    6     1
  mss   14  214   58  132    60
Number of rows analyzed: 20294
Number of columns analyzed: 278
tcga-mss-msi-annotated-no-cms1: 28 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 HLA-DQA2 HLA-DRB5 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
tcga-mss-msi-annotated-no-cms1: 85 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CSDA CTSC DDX10 DDX18 DDX5 DKC1 E2F1 EIF4A1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPA8 HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL10 RPL19 RPL22 RPL27 RPL27A RPL32 RPL5 RPL9 RPS13 RPS16 RPS19 RPS5 RPS6KA2 SFRS1 SFRS2 SFRS7 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
tcga-mss-msi-annotated-no-cms1: 3 of 88 genes missing from data set analyzed in set myc.sig: DSCR2 HNRPA2B1 HSPA9B
tcga-mss-msi-annotated-no-cms1: 50 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 CTPS BYSL SCD SOX4 WDR77 NLE1 PPIL1 CIRH1A ZNF511 ZNF593 DKC1 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 HNRPDL TREX2 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TDGF1 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
tcga-mss-msi-annotated-no-cms1: 28 of 78 genes missing from data set analyzed in set wnt: FLJ20315 NOB1P PSF1 PMSCL1 RNU3IP2 HIG2 C1orf33 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 C16orf35 CGI-96 C20orf64 C12orf14 NOL1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-annotated-no-cms1 wnt vs CIRC: t = -7.16772312556457 df = 276 nrow = 278 cor = -0.39614815084246 pval = 6.9847963099518e-12
tcga-mss-msi-annotated-no-cms1 tak1 vs CIRC: t = -1.07297584012558 df = 276 nrow = 278 cor = -0.064451273208696 pval = 0.28421919478325
tcga-mss-msi-annotated-no-cms1 wnt vs myc.sig: t = 32.1863024961148 df = 276 nrow = 278 cor = 0.888609825973405 pval = 2.01588326488796e-95
tcga-mss-msi-annotated-no-cms1 CIRC vs neoantigens: t = 1.8739538684082 df = 275 nrow = 277 cor = 0.112288988841077 pval = 0.0619970614440719

tcga-mss-msi-annotated-no-cms1: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10750, n_WT = 172, n_MT = 106, p = 0.0121093598372082
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9617, n_WT = 172, n_MT = 106, p = 0.442051911936875
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8157, n_WT = 172, n_MT = 106, p = 0.140969925634235
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9914, n_WT = 172, n_MT = 106, p = 0.220611388718154
tcga-mss-msi-annotated-no-cms1: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8911, n_WT = 172, n_MT = 106, p = 0.753446879521153
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8719, n_WT = 172, n_MT = 106, p = 0.542526981634952
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7663, n_WT = 171, n_MT = 106, p = 0.0307807802805391

tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1906, n_CMS2 = 134, n_CMS3 = 35, p = 0.0889098757704261
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1139, n_CMS2 = 134, n_CMS3 = 35, p = 2.91414375496482e-06
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1751, n_CMS2 = 134, n_CMS3 = 35, p = 0.0213067449272818
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1828, n_CMS2 = 134, n_CMS3 = 35, p = 0.0450936176798174
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3280, n_CMS2 = 134, n_CMS3 = 35, p = 0.000288485483160944
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2890, n_CMS2 = 134, n_CMS3 = 35, p = 0.034651543818701
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1980.5, n_CMS2 = 134, n_CMS3 = 35, p = 0.175905507483851
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2117, n_CMS2 = 134, n_CMS4 = 81, p = 7.02496068606718e-14
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2278, n_CMS2 = 134, n_CMS4 = 81, p = 1.05482298006014e-12
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3507, n_CMS2 = 134, n_CMS4 = 81, p = 1.40760675674535e-05
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2561, n_CMS2 = 134, n_CMS4 = 81, p = 8.99767699074349e-11
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 9122, n_CMS2 = 134, n_CMS4 = 81, p = 6.35604837624754e-17
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8925, n_CMS2 = 134, n_CMS4 = 81, p = 2.51797147984181e-15
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5168, n_CMS2 = 134, n_CMS4 = 81, p = 0.619702397780442
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1121, n_CMS2 = 134, n_NOLBL = 28, p = 0.000831350906977053
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1155, n_CMS2 = 134, n_NOLBL = 28, p = 0.00141519757159751
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1543, n_CMS2 = 134, n_NOLBL = 28, p = 0.140792825305331
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1186, n_CMS2 = 134, n_NOLBL = 28, p = 0.00225649927773907
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2350, n_CMS2 = 134, n_NOLBL = 28, p = 0.0359564188280824
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2119, n_CMS2 = 134, n_NOLBL = 28, p = 0.282741918180803
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1653.5, n_CMS2 = 134, n_NOLBL = 28, p = 0.353519620989398


tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 284, n_CMS2 = 41, n_CMS3 = 23, p = 0.00817148291138145
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 212, n_CMS2 = 41, n_CMS3 = 23, p = 0.000187331428762152
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 414, n_CMS2 = 41, n_CMS3 = 23, p = 0.428041291929672
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 289, n_CMS2 = 41, n_CMS3 = 23, p = 0.0101263134924805
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 708, n_CMS2 = 41, n_CMS3 = 23, p = 0.000726750121485624
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 656, n_CMS2 = 41, n_CMS3 = 23, p = 0.00930005100463402
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2 = 41, n_CMS3 = 23, p = 0.594862093429313
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 116, n_CMS2 = 41, n_CMS4 = 25, p = 1.36664401884186e-08
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 107, n_CMS2 = 41, n_CMS4 = 25, p = 5.19835180940529e-09
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 267, n_CMS2 = 41, n_CMS4 = 25, p = 0.0009484735671893
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 110, n_CMS2 = 41, n_CMS4 = 25, p = 7.21468388832661e-09
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 909, n_CMS2 = 41, n_CMS4 = 25, p = 1.36664401884186e-08
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 926, n_CMS2 = 41, n_CMS4 = 25, p = 2.1068735391955e-09
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2 = 41, n_CMS4 = 25, p = 1
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 126, n_CMS2 = 41, n_NOLBL = 17, p = 7.20358840030812e-05
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 187, n_CMS2 = 41, n_NOLBL = 17, p = 0.00516746377560274
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 227, n_CMS2 = 41, n_NOLBL = 17, p = 0.0378762896354627
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 133, n_CMS2 = 41, n_NOLBL = 17, p = 0.000128998098226766
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 473, n_CMS2 = 41, n_NOLBL = 17, p = 0.0332299378626706
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 424, n_CMS2 = 41, n_NOLBL = 17, p = 0.202214892754347
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2 = 41, n_NOLBL = 17, p = 0.0152617440877099

tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1153, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.000277251372958375
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1577, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.112174135151795
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1959, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.801760500465988
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1300, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.00343435427649365
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2144, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.252500571360156
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2164, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.214656759588873
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2044.5, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.441306704341132
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 284, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.00817148291138145
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 212, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000187331428762152
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 414, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.428041291929672
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 289, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0101263134924805
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 708, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000726750121485624
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 656, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.00930005100463402
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 433, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.594862093429313
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 82, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.000256939599340014
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 50, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 5.35075800875105e-06
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 148, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0370659349500604
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 101, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.00148802097607671
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 345, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0350880781916273
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 307, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.201325110948483
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 215.5, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.523657178039454
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 116, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1.36664401884186e-08
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 5.19835180940529e-09
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 267, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.0009484735671893
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 7.21468388832661e-09
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 909, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1.36664401884186e-08
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 926, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 2.1068735391955e-09
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 513, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 170, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 9.43385655331673e-13
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 423, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.21712016204261e-07
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 841, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.0252002126232531
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 338, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 3.38703711312013e-09
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 2011, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 3.00157232116044e-10
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1971, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.89472912662226e-09
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.812344687460441
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 126, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 7.20358840030812e-05
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 187, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.00516746377560274
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 227, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0378762896354627
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.000128998098226766
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 473, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0332299378626706
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 424, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.202214892754347
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test with continuity correction: W = 206, n_CMS2-MT = 41, n_NOLBL-MT = 17, p = 0.0152617440877099
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 120, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0170904196781372
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 92, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.00205557554780918
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 257, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.492692949318259
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.038002252842376
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.097744328129793
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 280, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.229884325101543
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test with continuity correction: W = 329, n_CMS2-MT = 41, n_NOLBL-WT = 11, p = 0.0209489707664498

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model with interaction for neoantigens
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 773, n_MT = 25, n_WT = 56, p = 0.458549136308975
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 687, n_MT = 25, n_WT = 56, p = 0.898307520633756
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 547, n_MT = 25, n_WT = 56, p = 0.118959502513599
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 610, n_MT = 25, n_WT = 56, p = 0.360167716906832
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 672, n_MT = 25, n_WT = 56, p = 0.778588259881065
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 709, n_MT = 25, n_WT = 56, p = 0.930748004808526
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 683, n_MT = 25, n_WT = 56, p = 0.866016636827914
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2660, n_MT = 41, n_WT = 93, p = 0.000277251372958375
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2236, n_MT = 41, n_WT = 93, p = 0.112174135151795
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1854, n_MT = 41, n_WT = 93, p = 0.801760500465988
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2513, n_MT = 41, n_WT = 93, p = 0.00343435427649365
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1669, n_MT = 41, n_WT = 93, p = 0.252500571360156
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1649, n_MT = 41, n_WT = 93, p = 0.214656759588873
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1727.5, n_MT = 41, n_WT = 93, p = 0.441306704341132
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 81, n_MT = 17, n_WT = 11, p = 0.578432051887429
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 112, n_MT = 17, n_WT = 11, p = 0.403501693661877
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 46, n_MT = 17, n_WT = 11, p = 0.025216702104574
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 17, n_WT = 11, p = 0.643498750592572
tcga-mss-msi-annotated-no-cms1: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 95, n_MT = 17, n_WT = 11, p = 0.963130885556515
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 17, n_WT = 11, p = 1
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens NOLBL MT vs WT using Wilcoxon rank sum test with continuity correction: W = 24, n_MT = 17, n_WT = 11, p = 0.00116033825466856
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 169, n_MT = 23, n_WT = 12, p = 0.29378493041779
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 197, n_MT = 23, n_WT = 12, p = 0.0408102349350795
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 189, n_MT = 23, n_WT = 12, p = 0.0791312236368835
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 23, n_WT = 12, p = 0.460505855461035
tcga-mss-msi-annotated-no-cms1: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 147, n_MT = 23, n_WT = 12, p = 0.770966011458062
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 151, n_MT = 23, n_WT = 12, p = 0.668423000585534
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens CMS3 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 139, n_MT = 23, n_WT = 12, p = 0.986132610427574

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing linear model for neoantigens
Computing rectum vs left
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2884, n_rectum = 54, n_left = 125, p = 0.123196898062462
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3274, n_rectum = 54, n_left = 125, p = 0.75212317432629
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3445, n_rectum = 54, n_left = 125, p = 0.827103887771301
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2863, n_rectum = 54, n_left = 125, p = 0.107947049342366
tcga-mss-msi-annotated-no-cms1: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3074, n_rectum = 54, n_left = 125, p = 0.344975298775732
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3066, n_rectum = 54, n_left = 125, p = 0.332284826738317
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3435, n_rectum = 54, n_left = 125, p = 0.851644256351317
Computing right vs left
tcga-mss-msi-annotated-no-cms1: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 5344, n_right = 97, n_left = 125, p = 0.130383360286549
tcga-mss-msi-annotated-no-cms1: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 5754, n_right = 97, n_left = 125, p = 0.516431737648455
tcga-mss-msi-annotated-no-cms1: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5855, n_right = 97, n_left = 125, p = 0.662777598804234
tcga-mss-msi-annotated-no-cms1: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 5110, n_right = 97, n_left = 125, p = 0.0449039001189254
tcga-mss-msi-annotated-no-cms1: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 5945, n_right = 97, n_left = 125, p = 0.805310028223077
tcga-mss-msi-annotated-no-cms1: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 5818, n_right = 97, n_left = 125, p = 0.607232110254066
tcga-mss-msi-annotated-no-cms1: Analyzing neoantigens site: right vs leftWilcoxon rank sum test with continuity correction: W = 4205, n_right = 97, n_left = 125, p = 0.000139558312774605

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Plotting neoantigens ~ site
There were 50 or more warnings (use warnings() to see the first 50)
Doing KFS analysis
Number of rows analyzed: 20534
Number of columns analyzed: 290
kfs-all: 26 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
kfs-all: 2 of 28 genes missing from data set analyzed in set CIRC: HLA-DQA2 HLA-DRB5
kfs-all: 75 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CTSC DDX10 DDX18 DDX5 E2F1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL19 RPL22 RPL27 RPL27A RPL32 RPL9 RPS16 RPS19 RPS5 RPS6KA2 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
kfs-all: 13 of 88 genes missing from data set analyzed in set myc.sig: CSDA DKC1 DSCR2 EIF4A1 HNRPA2B1 HSPA8 HSPA9B RPL10 RPL5 RPS13 SFRS1 SFRS2 SFRS7
kfs-all: 44 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 BYSL SCD SOX4 WDR77 NLE1 PPIL1 ZNF511 ZNF593 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
kfs-all: 34 of 78 genes missing from data set analyzed in set wnt: FLJ20315 CTPS NOB1P PSF1 PMSCL1 RNU3IP2 CIRH1A HIG2 C1orf33 DKC1 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 HNRPDL C16orf35 TREX2 CGI-96 C20orf64 C12orf14 NOL1 TDGF1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-all wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-all tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-all wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-all: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12084, n_WT = 175, n_MT = 115, p = 0.00381629339682518
kfs-all: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11133, n_WT = 175, n_MT = 115, p = 0.125608455664889
kfs-all: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9695, n_WT = 175, n_MT = 115, p = 0.59934536012692
kfs-all: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10654, n_WT = 175, n_MT = 115, p = 0.397560023143556
kfs-all: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8967, n_WT = 175, n_MT = 115, p = 0.117012405040246
kfs-all: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9479, n_WT = 175, n_MT = 115, p = 0.403979374642653

kfs-all: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2070, n_CMS2 = 106, n_CMS1 = 26, p = 7.60378857272565e-05
kfs-all: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2357, n_CMS2 = 106, n_CMS1 = 26, p = 2.15983955500033e-08
kfs-all: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1664, n_CMS2 = 106, n_CMS1 = 26, p = 0.102354261820411
kfs-all: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1781, n_CMS2 = 106, n_CMS1 = 26, p = 0.0212796956244183
kfs-all: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1243, n_CMS2 = 106, n_CMS1 = 26, p = 0.441555688893126
kfs-all: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1429, n_CMS2 = 106, n_CMS1 = 26, p = 0.772622758785752
kfs-all: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2420, n_CMS2 = 106, n_CMS3 = 48, p = 0.629986344622462
kfs-all: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1227, n_CMS2 = 106, n_CMS3 = 48, p = 2.8158333978293e-07
kfs-all: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2538, n_CMS2 = 106, n_CMS3 = 48, p = 0.982883275602073
kfs-all: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1921, n_CMS2 = 106, n_CMS3 = 48, p = 0.0151725404484379
kfs-all: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3676, n_CMS2 = 106, n_CMS3 = 48, p = 1.0160457710484e-05
kfs-all: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3579, n_CMS2 = 106, n_CMS3 = 48, p = 5.45198640139849e-05
kfs-all: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2166, n_CMS2 = 106, n_CMS4 = 78, p = 3.57087557384974e-08
kfs-all: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1441, n_CMS2 = 106, n_CMS4 = 78, p = 4.64441316496643e-14
kfs-all: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2933, n_CMS2 = 106, n_CMS4 = 78, p = 0.000772306042718963
kfs-all: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2699, n_CMS2 = 106, n_CMS4 = 78, p = 5.87053837385265e-05
kfs-all: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7074, n_CMS2 = 106, n_CMS4 = 78, p = 1.82008610804473e-16
kfs-all: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7328, n_CMS2 = 106, n_CMS4 = 78, p = 3.72567554753433e-19
kfs-all: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1142, n_CMS2 = 106, n_NOLBL = 32, p = 0.00523235264049533
kfs-all: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 882, n_CMS2 = 106, n_NOLBL = 32, p = 4.05976090786589e-05
kfs-all: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1399, n_CMS2 = 106, n_NOLBL = 32, p = 0.134699972724935
kfs-all: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1340, n_CMS2 = 106, n_NOLBL = 32, p = 0.0728972824133382
kfs-all: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2238, n_CMS2 = 106, n_NOLBL = 32, p = 0.00629835196123394
kfs-all: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2296, n_CMS2 = 106, n_NOLBL = 32, p = 0.00249096654347539


kfs-all: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 181, n_CMS2 = 36, n_CMS1 = 6, p = 0.0065931015866831
kfs-all: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 130, n_CMS2 = 36, n_CMS1 = 6, p = 0.449408344145186
kfs-all: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 128, n_CMS2 = 36, n_CMS1 = 6, p = 0.493066244029017
kfs-all: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 136, n_CMS2 = 36, n_CMS1 = 6, p = 0.331753906850184
kfs-all: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 89, n_CMS2 = 36, n_CMS1 = 6, p = 0.515668767273389
kfs-all: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 112, n_CMS2 = 36, n_CMS1 = 6, p = 0.902446268299927
kfs-all: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 421, n_CMS2 = 36, n_CMS3 = 30, p = 0.12760926993836
kfs-all: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 368, n_CMS2 = 36, n_CMS3 = 30, p = 0.0265165337046651
kfs-all: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 472, n_CMS2 = 36, n_CMS3 = 30, p = 0.387200808016325
kfs-all: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 388, n_CMS2 = 36, n_CMS3 = 30, p = 0.0506126860801661
kfs-all: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 730, n_CMS2 = 36, n_CMS3 = 30, p = 0.0139734605326363
kfs-all: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 692, n_CMS2 = 36, n_CMS3 = 30, p = 0.0506126860801661
kfs-all: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 249, n_CMS2 = 36, n_CMS4 = 28, p = 0.000420405301276834
kfs-all: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 206, n_CMS2 = 36, n_CMS4 = 28, p = 2.94553861882198e-05
kfs-all: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 331, n_CMS2 = 36, n_CMS4 = 28, p = 0.018823988431213
kfs-all: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 326, n_CMS2 = 36, n_CMS4 = 28, p = 0.0155593553440074
kfs-all: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 807, n_CMS2 = 36, n_CMS4 = 28, p = 2.08743224770021e-05
kfs-all: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 877, n_CMS2 = 36, n_CMS4 = 28, p = 6.45066439594425e-08
kfs-all: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 134, n_CMS2 = 36, n_NOLBL = 15, p = 0.00425079314144008
kfs-all: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 193, n_CMS2 = 36, n_NOLBL = 15, p = 0.114485809697035
kfs-all: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 236, n_CMS2 = 36, n_NOLBL = 15, p = 0.492781171639813
kfs-all: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 178, n_CMS2 = 36, n_NOLBL = 15, p = 0.0579778705213799
kfs-all: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 320, n_CMS2 = 36, n_NOLBL = 15, p = 0.309806809588468
kfs-all: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 300, n_CMS2 = 36, n_NOLBL = 15, p = 0.54600708207611

kfs-all: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 920, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0235222706633201
kfs-all: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1346, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.568419733566188
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1235, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.870170175460346
kfs-all: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1112, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.325120653397329
kfs-all: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1294, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.823160101885212
kfs-all: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1238, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.88595139325827
kfs-all: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 35, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0065931015866831
kfs-all: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 86, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.449408344145186
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 88, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.493066244029017
kfs-all: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 80, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.331753906850184
kfs-all: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 127, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.515668767273389
kfs-all: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 104, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.902446268299927
kfs-all: Analyzing CIRC CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 143, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.00012051048232834
kfs-all: Analyzing HIF1A CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 60, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 1.4410853561162e-08
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 265, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.106536507713336
kfs-all: Analyzing CIITA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 229, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0247268584092454
kfs-all: Analyzing wnt CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 394, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.569901376780406
kfs-all: Analyzing myc.sig CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 332, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.641013423688593
kfs-all: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 421, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.12760926993836
kfs-all: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 368, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0265165337046651
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 472, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.387200808016325
kfs-all: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 388, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0506126860801661
kfs-all: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 730, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0139734605326363
kfs-all: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 692, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0506126860801661
kfs-all: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 223, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0648008328361439
kfs-all: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 103, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 1.9419314269056e-05
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 406, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.135794503014336
kfs-all: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 219, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0546122577341001
kfs-all: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 533, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 6.18609070075246e-05
kfs-all: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 518, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.00022994680687806
kfs-all: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 249, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.000420405301276834
kfs-all: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 206, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 2.94553861882198e-05
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 331, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.018823988431213
kfs-all: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 326, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0155593553440074
kfs-all: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 807, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 2.08743224770021e-05
kfs-all: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 877, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 6.45066439594425e-08
kfs-all: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 283, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 6.78798623519983e-08
kfs-all: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 347, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.32176101886717e-06
kfs-all: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 641, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.0236450900317977
kfs-all: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 515, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.000763160585138901
kfs-all: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1612, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 4.71518106604633e-10
kfs-all: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1598, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.0231961752354e-09
kfs-all: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 134, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.00425079314144008
kfs-all: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 193, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.114485809697035
kfs-all: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 236, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.492781171639813
kfs-all: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 178, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.0579778705213799
kfs-all: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 320, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.309806809588468
kfs-all: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.54600708207611
kfs-all: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 170, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00886020591554157
kfs-all: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 162, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00542287558326552
kfs-all: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.121191473817976
kfs-all: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 238, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.200475590530408
kfs-all: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 452, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00477410171768445
kfs-all: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 461, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00262657309942444

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
kfs-all: Analyzing CIRC CMS1 MT vs WT using Wilcoxon rank sum test: W = 72, n_MT = 6, n_WT = 20, p = 0.494192763757981
kfs-all: Analyzing HIF1A CMS1 MT vs WT using Wilcoxon rank sum test: W = 97, n_MT = 6, n_WT = 20, p = 0.023298440689745
kfs-all: Analyzing BHLHE40 CMS1 MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 6, n_WT = 20, p = 0.882274247491639
kfs-all: Analyzing CIITA CMS1 MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 6, n_WT = 20, p = 0.882274247491639
kfs-all: Analyzing wnt CMS1 MT vs WT using Wilcoxon rank sum test: W = 65, n_MT = 6, n_WT = 20, p = 0.78974069408852
kfs-all: Analyzing myc.sig CMS1 MT vs WT using Wilcoxon rank sum test: W = 70, n_MT = 6, n_WT = 20, p = 0.572740303175086
kfs-all: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 125, n_MT = 15, n_WT = 17, p = 0.940655598912485
kfs-all: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 15, n_WT = 17, p = 0.230410321862272
kfs-all: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 147, n_MT = 15, n_WT = 17, p = 0.478383339456474
kfs-all: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 125, n_MT = 15, n_WT = 17, p = 0.940655598912485
kfs-all: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 91, n_MT = 15, n_WT = 17, p = 0.176456045463403
kfs-all: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 78, n_MT = 15, n_WT = 17, p = 0.0636809813825402
kfs-all: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1600, n_MT = 36, n_WT = 70, p = 0.0235222706633201
kfs-all: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1174, n_MT = 36, n_WT = 70, p = 0.568419733566188
kfs-all: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1285, n_MT = 36, n_WT = 70, p = 0.870170175460346
kfs-all: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1408, n_MT = 36, n_WT = 70, p = 0.325120653397329
kfs-all: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1226, n_MT = 36, n_WT = 70, p = 0.823160101885212
kfs-all: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1282, n_MT = 36, n_WT = 70, p = 0.88595139325827
kfs-all: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 870, n_MT = 28, n_WT = 50, p = 0.0774695039146408
kfs-all: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 809, n_MT = 28, n_WT = 50, p = 0.258405669587015
kfs-all: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 640, n_MT = 28, n_WT = 50, p = 0.535409715774469
kfs-all: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 790, n_MT = 28, n_WT = 50, p = 0.351203234230733
kfs-all: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 534, n_MT = 28, n_WT = 50, p = 0.0847266226587162
kfs-all: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 601, n_MT = 28, n_WT = 50, p = 0.30488943569888
kfs-all: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 288, n_MT = 30, n_WT = 18, p = 0.712121305956866
kfs-all: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 366, n_MT = 30, n_WT = 18, p = 0.0411372936349449
kfs-all: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 190, n_MT = 30, n_WT = 18, p = 0.0906046579528343
kfs-all: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 273, n_MT = 30, n_WT = 18, p = 0.957977685436268
kfs-all: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 145, n_MT = 30, n_WT = 18, p = 0.00710750551922749
kfs-all: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 169, n_MT = 30, n_WT = 18, p = 0.0313508718666899

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing rectum vs left
kfs-all: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2624, n_rectum = 188, n_left = 28, p = 0.980606268877483
kfs-all: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2991, n_rectum = 188, n_left = 28, p = 0.245250846061419
kfs-all: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2633, n_rectum = 188, n_left = 28, p = 0.998706957821793
kfs-all: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2460, n_rectum = 188, n_left = 28, p = 0.578305237183719
kfs-all: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2614, n_rectum = 188, n_left = 28, p = 0.954767758985108
kfs-all: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2710, n_rectum = 188, n_left = 28, p = 0.801666244222022
Computing right vs left
kfs-all: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 886, n_right = 74, n_left = 28, p = 0.262273892076771
kfs-all: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 943, n_right = 74, n_left = 28, p = 0.487923292257624
kfs-all: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1333, n_right = 74, n_left = 28, p = 0.0261942787892062
kfs-all: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 755, n_right = 74, n_left = 28, p = 0.035435839384505
kfs-all: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 958, n_right = 74, n_left = 28, p = 0.561147843501288
kfs-all: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 945, n_right = 74, n_left = 28, p = 0.497379598574922

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
MSI nrow =  307 
  clusters Freq
1        1   88
2        2  219
MSI clusters: 1
MSS clusters: 2
[1] -7.580742e-16
[1] -2.182282e-15
Has CMS
Has TYMS
[1] 1.00 5.00 0.25 0.25 2.00
[1] 1.0 5.0 5.0 0.5 1.0 0.5
     [,1] [,2] [,3] [,4] [,5]
[1,]   NA    2    4    6   NA
[2,]    1    3    5    7    9
[3,]    1    3    5    7   10
[4,]   NA   NA   NA   NA   NA
[5,]   NA    8   NA   NA   NA
[6,]   NA   NA   NA   NA   NA
[1] 10
Beeswarm: TYMS vs Inferred.Status W = 11946 p = 0.00102436427595825 n_MSI = 88, n_MSS = 219
Number of rows analyzed: 20534
Number of columns analyzed: 290
kfs-all-msi-inferred: 26 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
kfs-all-msi-inferred: 2 of 28 genes missing from data set analyzed in set CIRC: HLA-DQA2 HLA-DRB5
kfs-all-msi-inferred: 75 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CTSC DDX10 DDX18 DDX5 E2F1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL19 RPL22 RPL27 RPL27A RPL32 RPL9 RPS16 RPS19 RPS5 RPS6KA2 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
kfs-all-msi-inferred: 13 of 88 genes missing from data set analyzed in set myc.sig: CSDA DKC1 DSCR2 EIF4A1 HNRPA2B1 HSPA8 HSPA9B RPL10 RPL5 RPS13 SFRS1 SFRS2 SFRS7
kfs-all-msi-inferred: 44 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 BYSL SCD SOX4 WDR77 NLE1 PPIL1 ZNF511 ZNF593 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
kfs-all-msi-inferred: 34 of 78 genes missing from data set analyzed in set wnt: FLJ20315 CTPS NOB1P PSF1 PMSCL1 RNU3IP2 CIRH1A HIG2 C1orf33 DKC1 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 HNRPDL C16orf35 TREX2 CGI-96 C20orf64 C12orf14 NOL1 TDGF1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-all-msi-inferred wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-all-msi-inferred tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-all-msi-inferred wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-all-msi-inferred: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12084, n_WT = 175, n_MT = 115, p = 0.00381629339682518
kfs-all-msi-inferred: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11133, n_WT = 175, n_MT = 115, p = 0.125608455664889
kfs-all-msi-inferred: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9695, n_WT = 175, n_MT = 115, p = 0.59934536012692
kfs-all-msi-inferred: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10654, n_WT = 175, n_MT = 115, p = 0.397560023143556
kfs-all-msi-inferred: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8967, n_WT = 175, n_MT = 115, p = 0.117012405040246
kfs-all-msi-inferred: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9479, n_WT = 175, n_MT = 115, p = 0.403979374642653

kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2070, n_CMS2 = 106, n_CMS1 = 26, p = 7.60378857272565e-05
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2357, n_CMS2 = 106, n_CMS1 = 26, p = 2.15983955500033e-08
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1664, n_CMS2 = 106, n_CMS1 = 26, p = 0.102354261820411
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1781, n_CMS2 = 106, n_CMS1 = 26, p = 0.0212796956244183
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1243, n_CMS2 = 106, n_CMS1 = 26, p = 0.441555688893126
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1429, n_CMS2 = 106, n_CMS1 = 26, p = 0.772622758785752
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2420, n_CMS2 = 106, n_CMS3 = 48, p = 0.629986344622462
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1227, n_CMS2 = 106, n_CMS3 = 48, p = 2.8158333978293e-07
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2538, n_CMS2 = 106, n_CMS3 = 48, p = 0.982883275602073
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1921, n_CMS2 = 106, n_CMS3 = 48, p = 0.0151725404484379
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3676, n_CMS2 = 106, n_CMS3 = 48, p = 1.0160457710484e-05
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3579, n_CMS2 = 106, n_CMS3 = 48, p = 5.45198640139849e-05
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2166, n_CMS2 = 106, n_CMS4 = 78, p = 3.57087557384974e-08
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1441, n_CMS2 = 106, n_CMS4 = 78, p = 4.64441316496643e-14
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2933, n_CMS2 = 106, n_CMS4 = 78, p = 0.000772306042718963
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2699, n_CMS2 = 106, n_CMS4 = 78, p = 5.87053837385265e-05
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7074, n_CMS2 = 106, n_CMS4 = 78, p = 1.82008610804473e-16
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7328, n_CMS2 = 106, n_CMS4 = 78, p = 3.72567554753433e-19
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1142, n_CMS2 = 106, n_NOLBL = 32, p = 0.00523235264049533
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 882, n_CMS2 = 106, n_NOLBL = 32, p = 4.05976090786589e-05
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1399, n_CMS2 = 106, n_NOLBL = 32, p = 0.134699972724935
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1340, n_CMS2 = 106, n_NOLBL = 32, p = 0.0728972824133382
kfs-all-msi-inferred: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2238, n_CMS2 = 106, n_NOLBL = 32, p = 0.00629835196123394
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 2296, n_CMS2 = 106, n_NOLBL = 32, p = 0.00249096654347539


kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 181, n_CMS2 = 36, n_CMS1 = 6, p = 0.0065931015866831
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 130, n_CMS2 = 36, n_CMS1 = 6, p = 0.449408344145186
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 128, n_CMS2 = 36, n_CMS1 = 6, p = 0.493066244029017
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 136, n_CMS2 = 36, n_CMS1 = 6, p = 0.331753906850184
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 89, n_CMS2 = 36, n_CMS1 = 6, p = 0.515668767273389
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 112, n_CMS2 = 36, n_CMS1 = 6, p = 0.902446268299927
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 421, n_CMS2 = 36, n_CMS3 = 30, p = 0.12760926993836
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 368, n_CMS2 = 36, n_CMS3 = 30, p = 0.0265165337046651
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 472, n_CMS2 = 36, n_CMS3 = 30, p = 0.387200808016325
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 388, n_CMS2 = 36, n_CMS3 = 30, p = 0.0506126860801661
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 730, n_CMS2 = 36, n_CMS3 = 30, p = 0.0139734605326363
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 692, n_CMS2 = 36, n_CMS3 = 30, p = 0.0506126860801661
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 249, n_CMS2 = 36, n_CMS4 = 28, p = 0.000420405301276834
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 206, n_CMS2 = 36, n_CMS4 = 28, p = 2.94553861882198e-05
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 331, n_CMS2 = 36, n_CMS4 = 28, p = 0.018823988431213
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 326, n_CMS2 = 36, n_CMS4 = 28, p = 0.0155593553440074
kfs-all-msi-inferred: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 807, n_CMS2 = 36, n_CMS4 = 28, p = 2.08743224770021e-05
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 877, n_CMS2 = 36, n_CMS4 = 28, p = 6.45066439594425e-08
kfs-all-msi-inferred: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 134, n_CMS2 = 36, n_NOLBL = 15, p = 0.00425079314144008
kfs-all-msi-inferred: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 193, n_CMS2 = 36, n_NOLBL = 15, p = 0.114485809697035
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 236, n_CMS2 = 36, n_NOLBL = 15, p = 0.492781171639813
kfs-all-msi-inferred: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 178, n_CMS2 = 36, n_NOLBL = 15, p = 0.0579778705213799
kfs-all-msi-inferred: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 320, n_CMS2 = 36, n_NOLBL = 15, p = 0.309806809588468
kfs-all-msi-inferred: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 300, n_CMS2 = 36, n_NOLBL = 15, p = 0.54600708207611

kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 920, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0235222706633201
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1346, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.568419733566188
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1235, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.870170175460346
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1112, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.325120653397329
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1294, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.823160101885212
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1238, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.88595139325827
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 35, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0065931015866831
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 86, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.449408344145186
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 88, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.493066244029017
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 80, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.331753906850184
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 127, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.515668767273389
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 104, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.902446268299927
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 143, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.00012051048232834
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 60, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 1.4410853561162e-08
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 265, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.106536507713336
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 229, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0247268584092454
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 394, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.569901376780406
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 332, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.641013423688593
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 421, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.12760926993836
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 368, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0265165337046651
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 472, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.387200808016325
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 388, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0506126860801661
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 730, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0139734605326363
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 692, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0506126860801661
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 223, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0648008328361439
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 103, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 1.9419314269056e-05
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 406, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.135794503014336
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 219, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0546122577341001
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 533, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 6.18609070075246e-05
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 518, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.00022994680687806
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 249, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.000420405301276834
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 206, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 2.94553861882198e-05
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 331, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.018823988431213
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 326, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0155593553440074
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 807, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 2.08743224770021e-05
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 877, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 6.45066439594425e-08
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 283, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 6.78798623519983e-08
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 347, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.32176101886717e-06
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 641, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.0236450900317977
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 515, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.000763160585138901
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1612, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 4.71518106604633e-10
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1598, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.0231961752354e-09
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 134, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.00425079314144008
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 193, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.114485809697035
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 236, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.492781171639813
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 178, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.0579778705213799
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 320, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.309806809588468
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 36, n_NOLBL-MT = 15, p = 0.54600708207611
kfs-all-msi-inferred: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 170, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00886020591554157
kfs-all-msi-inferred: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 162, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00542287558326552
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.121191473817976
kfs-all-msi-inferred: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 238, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.200475590530408
kfs-all-msi-inferred: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 452, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00477410171768445
kfs-all-msi-inferred: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 461, n_CMS2-MT = 36, n_NOLBL-WT = 17, p = 0.00262657309942444

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
kfs-all-msi-inferred: Analyzing CIRC CMS1 MT vs WT using Wilcoxon rank sum test: W = 72, n_MT = 6, n_WT = 20, p = 0.494192763757981
kfs-all-msi-inferred: Analyzing HIF1A CMS1 MT vs WT using Wilcoxon rank sum test: W = 97, n_MT = 6, n_WT = 20, p = 0.023298440689745
kfs-all-msi-inferred: Analyzing BHLHE40 CMS1 MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 6, n_WT = 20, p = 0.882274247491639
kfs-all-msi-inferred: Analyzing CIITA CMS1 MT vs WT using Wilcoxon rank sum test: W = 63, n_MT = 6, n_WT = 20, p = 0.882274247491639
kfs-all-msi-inferred: Analyzing wnt CMS1 MT vs WT using Wilcoxon rank sum test: W = 65, n_MT = 6, n_WT = 20, p = 0.78974069408852
kfs-all-msi-inferred: Analyzing myc.sig CMS1 MT vs WT using Wilcoxon rank sum test: W = 70, n_MT = 6, n_WT = 20, p = 0.572740303175086
kfs-all-msi-inferred: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 125, n_MT = 15, n_WT = 17, p = 0.940655598912485
kfs-all-msi-inferred: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 15, n_WT = 17, p = 0.230410321862272
kfs-all-msi-inferred: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 147, n_MT = 15, n_WT = 17, p = 0.478383339456474
kfs-all-msi-inferred: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 125, n_MT = 15, n_WT = 17, p = 0.940655598912485
kfs-all-msi-inferred: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 91, n_MT = 15, n_WT = 17, p = 0.176456045463403
kfs-all-msi-inferred: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 78, n_MT = 15, n_WT = 17, p = 0.0636809813825402
kfs-all-msi-inferred: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1600, n_MT = 36, n_WT = 70, p = 0.0235222706633201
kfs-all-msi-inferred: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1174, n_MT = 36, n_WT = 70, p = 0.568419733566188
kfs-all-msi-inferred: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1285, n_MT = 36, n_WT = 70, p = 0.870170175460346
kfs-all-msi-inferred: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1408, n_MT = 36, n_WT = 70, p = 0.325120653397329
kfs-all-msi-inferred: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1226, n_MT = 36, n_WT = 70, p = 0.823160101885212
kfs-all-msi-inferred: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1282, n_MT = 36, n_WT = 70, p = 0.88595139325827
kfs-all-msi-inferred: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 870, n_MT = 28, n_WT = 50, p = 0.0774695039146408
kfs-all-msi-inferred: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 809, n_MT = 28, n_WT = 50, p = 0.258405669587015
kfs-all-msi-inferred: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 640, n_MT = 28, n_WT = 50, p = 0.535409715774469
kfs-all-msi-inferred: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 790, n_MT = 28, n_WT = 50, p = 0.351203234230733
kfs-all-msi-inferred: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 534, n_MT = 28, n_WT = 50, p = 0.0847266226587162
kfs-all-msi-inferred: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 601, n_MT = 28, n_WT = 50, p = 0.30488943569888
kfs-all-msi-inferred: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 288, n_MT = 30, n_WT = 18, p = 0.712121305956866
kfs-all-msi-inferred: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 366, n_MT = 30, n_WT = 18, p = 0.0411372936349449
kfs-all-msi-inferred: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 190, n_MT = 30, n_WT = 18, p = 0.0906046579528343
kfs-all-msi-inferred: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 273, n_MT = 30, n_WT = 18, p = 0.957977685436268
kfs-all-msi-inferred: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 145, n_MT = 30, n_WT = 18, p = 0.00710750551922749
kfs-all-msi-inferred: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 169, n_MT = 30, n_WT = 18, p = 0.0313508718666899

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing rectum vs left
kfs-all-msi-inferred: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2624, n_rectum = 188, n_left = 28, p = 0.980606268877483
kfs-all-msi-inferred: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2991, n_rectum = 188, n_left = 28, p = 0.245250846061419
kfs-all-msi-inferred: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2633, n_rectum = 188, n_left = 28, p = 0.998706957821793
kfs-all-msi-inferred: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2460, n_rectum = 188, n_left = 28, p = 0.578305237183719
kfs-all-msi-inferred: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2614, n_rectum = 188, n_left = 28, p = 0.954767758985108
kfs-all-msi-inferred: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2710, n_rectum = 188, n_left = 28, p = 0.801666244222022
Computing right vs left
kfs-all-msi-inferred: Analyzing CIRC site: right vs leftWilcoxon rank sum test with continuity correction: W = 886, n_right = 74, n_left = 28, p = 0.262273892076771
kfs-all-msi-inferred: Analyzing HIF1A site: right vs leftWilcoxon rank sum test with continuity correction: W = 943, n_right = 74, n_left = 28, p = 0.487923292257624
kfs-all-msi-inferred: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1333, n_right = 74, n_left = 28, p = 0.0261942787892062
kfs-all-msi-inferred: Analyzing CIITA site: right vs leftWilcoxon rank sum test with continuity correction: W = 755, n_right = 74, n_left = 28, p = 0.035435839384505
kfs-all-msi-inferred: Analyzing wnt site: right vs leftWilcoxon rank sum test with continuity correction: W = 958, n_right = 74, n_left = 28, p = 0.561147843501288
kfs-all-msi-inferred: Analyzing myc.sig site: right vs leftWilcoxon rank sum test with continuity correction: W = 945, n_right = 74, n_left = 28, p = 0.497379598574922

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
Computing MSS vs MSI
kfs-all-msi-inferred: Analyzing CIRC status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 11063, n_MSS = 212, n_MSI = 78, p = 1.019523849464e-05
kfs-all-msi-inferred: Analyzing HIF1A status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 13345, n_MSS = 212, n_MSI = 78, p = 1.08662254933007e-15
kfs-all-msi-inferred: Analyzing BHLHE40 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8800, n_MSS = 212, n_MSI = 78, p = 0.401284782540407
kfs-all-msi-inferred: Analyzing CIITA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 10716, n_MSS = 212, n_MSI = 78, p = 0.000111080698110785
kfs-all-msi-inferred: Analyzing wnt status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5949, n_MSS = 212, n_MSI = 78, p = 0.000250933085765115
kfs-all-msi-inferred: Analyzing myc.sig status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 6507, n_MSS = 212, n_MSI = 78, p = 0.00543373319188357

Plotting CIRC ~ status
Plotting HIF1A ~ status
Plotting BHLHE40 ~ status
Plotting CIITA ~ status
Plotting wnt ~ status
Plotting myc.sig ~ status
Overlap of MSI and CMS1 in KFS inferred:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   29    1   13   38     7
  mss    1  109   36   47    26
Number of rows analyzed: 20534
Number of columns analyzed: 211
kfs-mss-msi-inferred-no-cms1: 26 of 28 genes from data set analyzed in set CIRC: HLA-DQA1 CTLA4 PDCD1LG2 ICAM1 CD274 STAT1 IRF1 IFNG GNLY TBX21 CCL5 LAG3 CD247 ICOS IL18RAP CXCL9 CXCL10 HLA-DPB1 HLA-DPA1 HLA-DMB HLA-DRA HLA-DMA CD80 HLA-DOA CD4 HAVCR2
kfs-mss-msi-inferred-no-cms1: 2 of 28 genes missing from data set analyzed in set CIRC: HLA-DQA2 HLA-DRB5
kfs-mss-msi-inferred-no-cms1: 75 of 88 genes from data set analyzed in set myc.sig: AKAP1 APEX1 BAX CAD CCKBR CCNB1 CCND2 CCT5 CDC25C CEBPZ CKS2 CTSC DDX10 DDX18 DDX5 E2F1 EIF4B ENO1 EXOSC8 FASN FOSL1 H2AFZ HSPD1 HSPE1 ID2 IMPA2 LTA4H MAT2A METTL1 MINA MSH2 MTHFD1 NAP1L1 NCL NME1 NPM1 NRAS NUP155 PA2G4 PCNA PHB POLD2 PPAT PPIA PPID PRDX3 PREP PRPS2 PSMB1 PTEN PYCR1 RPL19 RPL22 RPL27 RPL27A RPL32 RPL9 RPS16 RPS19 RPS5 RPS6KA2 SHMT1 SLC25A3 SLC39A6 SNRPB SNRPD3 SRM TERT TFRC TOP1 TXN TYMS UBE2C UCHL1 UXT
kfs-mss-msi-inferred-no-cms1: 13 of 88 genes missing from data set analyzed in set myc.sig: CSDA DKC1 DSCR2 EIF4A1 HNRPA2B1 HSPA8 HSPA9B RPL10 RPL5 RPS13 SFRS1 SFRS2 SFRS7
kfs-mss-msi-inferred-no-cms1: 44 of 78 genes from data set analyzed in set wnt: PHLDA1 SLC7A5 BYSL SCD SOX4 WDR77 NLE1 PPIL1 ZNF511 ZNF593 ODC1 AURKB WDR12 CDT1 NOC3L CAD XPOT YAP1 SRM NXT1 MRPS12 RHEB WDR3 CRTAP SF3A2 GEMIN5 IMP4 HEATR1 SLC19A1 PDCD11 ASCL2 TBX3 EPHB3 ZNRF3 IL20RA RHOBTB3 GEMIN4 ID3 FUT4 PIGW APEX1 SRPRB ZNRD1 TFB2M
kfs-mss-msi-inferred-no-cms1: 34 of 78 genes missing from data set analyzed in set wnt: FLJ20315 CTPS NOB1P PSF1 PMSCL1 RNU3IP2 CIRH1A HIG2 C1orf33 DKC1 LOC389362 HSPC111 MGC40397 LOC56902 SDCCAG16 FLJ10774 RAB9P40 RFP RRP41 HNRPDL C16orf35 TREX2 CGI-96 C20orf64 C12orf14 NOL1 TDGF1 SKB1 C11orf5 MGC16824 ZNF278 RPC62 JTV1 ZNF339
Estimating GSVA scores for 24 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 3 cores
  |                                                                              |                                                                      |   0%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |=========                                                             |  12%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==================                                                    |  25%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |==========================                                            |  38%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |===================================                                   |  50%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |============================================                          |  62%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |====================================================                  |  75%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |=============================================================         |  88%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-mss-msi-inferred-no-cms1 wnt vs CIRC: t = -3.23020603368078 df = 209 nrow = 211 cor = -0.218061018136961 pval = 0.00143684613896936
kfs-mss-msi-inferred-no-cms1 tak1 vs CIRC: t = 0.103983849729605 df = 209 nrow = 211 cor = 0.00719252723590502 pval = 0.917281879818365
kfs-mss-msi-inferred-no-cms1 wnt vs myc.sig: t = 28.7641064192965 df = 209 nrow = 211 cor = 0.893496118953304 pval = 1.32909498722966e-74

kfs-mss-msi-inferred-no-cms1: Analyzing CIRC vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5867, n_WT = 121, n_MT = 90, p = 0.336571144344835
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5112, n_WT = 121, n_MT = 90, p = 0.44841838592294
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5086, n_WT = 121, n_MT = 90, p = 0.413739358666058
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 4971, n_WT = 121, n_MT = 90, p = 0.28035815002357
kfs-mss-msi-inferred-no-cms1: Analyzing wnt vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5092, n_WT = 121, n_MT = 90, p = 0.421598149257727
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5452, n_WT = 121, n_MT = 90, p = 0.988176494018131

kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1559, n_CMS2 = 105, n_CMS3 = 35, p = 0.180955616108633
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1013, n_CMS2 = 105, n_CMS3 = 35, p = 7.32937141284531e-05
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1627, n_CMS2 = 105, n_CMS3 = 35, p = 0.312216388343319
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1207, n_CMS2 = 105, n_CMS3 = 35, p = 0.00243142969965082
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2763, n_CMS2 = 105, n_CMS3 = 35, p = 8.53224162761785e-06
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2805, n_CMS2 = 105, n_CMS3 = 35, p = 3.26362011718596e-06
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1576, n_CMS2 = 105, n_CMS4 = 46, p = 0.000698953453612531
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1261, n_CMS2 = 105, n_CMS4 = 46, p = 3.10861880672111e-06
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1738, n_CMS2 = 105, n_CMS4 = 46, p = 0.00623734332044265
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1931, n_CMS2 = 105, n_CMS4 = 46, p = 0.0506123088101036
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3843, n_CMS2 = 105, n_CMS4 = 46, p = 7.86763670522775e-09
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4027, n_CMS2 = 105, n_CMS4 = 46, p = 7.26086768016875e-11
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1032, n_CMS2 = 105, n_NOLBL = 25, p = 0.0981175713898458
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 795, n_CMS2 = 105, n_NOLBL = 25, p = 0.00225749461494751
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1091, n_CMS2 = 105, n_NOLBL = 25, p = 0.191716797244077
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1134, n_CMS2 = 105, n_NOLBL = 25, p = 0.293027846181533
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1694, n_CMS2 = 105, n_NOLBL = 25, p = 0.0244053048174625
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs NOLBL using Wilcoxon rank sum test with continuity correction: W = 1730, n_CMS2 = 105, n_NOLBL = 25, p = 0.0137644923071445


kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 249, n_CMS2 = 35, n_CMS3 = 23, p = 0.0141735664977531
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 304, n_CMS2 = 35, n_CMS3 = 23, p = 0.119898437761178
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 308, n_CMS2 = 35, n_CMS3 = 23, p = 0.135985723861392
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 236, n_CMS2 = 35, n_CMS3 = 23, p = 0.00759061481378195
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 538, n_CMS2 = 35, n_CMS3 = 23, p = 0.0310959078405375
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 550, n_CMS2 = 35, n_CMS3 = 23, p = 0.0186011445657478
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 194, n_CMS2 = 35, n_CMS4 = 18, p = 0.0226073469083172
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 170, n_CMS2 = 35, n_CMS4 = 18, p = 0.00583634050242009
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 219, n_CMS2 = 35, n_CMS4 = 18, p = 0.0726640162822521
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 190, n_CMS2 = 35, n_CMS4 = 18, p = 0.0183426801432757
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 481, n_CMS2 = 35, n_CMS4 = 18, p = 0.00144269680469389
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 540, n_CMS2 = 35, n_CMS4 = 18, p = 7.26616586024432e-06
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 132, n_CMS2 = 35, n_NOLBL = 14, p = 0.0115667303710805
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 179, n_CMS2 = 35, n_NOLBL = 14, p = 0.148684526454574
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 226, n_CMS2 = 35, n_NOLBL = 14, p = 0.685654082811247
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 165, n_CMS2 = 35, n_NOLBL = 14, p = 0.0783843274898296
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 303, n_CMS2 = 35, n_NOLBL = 14, p = 0.205758213735622
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 vs NOLBL (KRAS MT only) using Wilcoxon rank sum test: W = 286, n_CMS2 = 35, n_NOLBL = 14, p = 0.374372163475953

kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 928, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.0438539651986969
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1316, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.538434900578318
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1209, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.916088117248505
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1065, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.278269566302042
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1254, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.846386381650853
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1216, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.953924289291012
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 249, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.0141735664977531
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 304, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.119898437761178
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 308, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.135985723861392
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 236, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.00759061481378195
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 538, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.0310959078405375
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 550, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.0186011445657478
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 149, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.141487193713363
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 76, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.000680159295658766
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 247, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.378106171054396
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 138, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.0810261731369251
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 394, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 4.0071652929855e-07
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 385, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 2.39067274686492e-06
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 194, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.0226073469083172
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 170, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.00583634050242009
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 219, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.0726640162822521
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 190, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.0183426801432757
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 481, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.00144269680469389
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 540, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 7.26616586024432e-06
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 217, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.000100935716791647
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 293, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.0059738013958951
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 355, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.062522116361689
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 389, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.165612707307573
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 811, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 3.22512382306848e-06
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 792, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 1.38489629799278e-05
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.0115667303710805
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 179, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.148684526454574
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 226, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.685654082811247
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 165, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.0783843274898296
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 303, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.205758213735622
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs NOLBL-MT using Wilcoxon rank sum test: W = 286, n_CMS2-MT = 35, n_NOLBL-MT = 14, p = 0.374372163475953
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 150, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.283902654166182
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 133, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.13004272316787
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 128, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.0998306597471221
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 174, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.647571575452203
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 268, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.0525202498013821
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2-MT vs NOLBL-WT using Wilcoxon rank sum test: W = 275, n_CMS2-MT = 35, n_NOLBL-WT = 11, p = 0.0333197241473258

Computing linear model with interaction for CIRC
Computing linear model with interaction for HIF1A
Computing linear model with interaction for BHLHE40
Computing linear model with interaction for CIITA
Computing linear model with interaction for wnt
Computing linear model with interaction for myc.sig
Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC NOLBL MT vs WT using Wilcoxon rank sum test: W = 50, n_MT = 14, n_WT = 11, p = 0.149216134966572
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A NOLBL MT vs WT using Wilcoxon rank sum test: W = 77, n_MT = 14, n_WT = 11, p = 1
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 NOLBL MT vs WT using Wilcoxon rank sum test: W = 94, n_MT = 14, n_WT = 11, p = 0.373028671422803
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA NOLBL MT vs WT using Wilcoxon rank sum test: W = 59, n_MT = 14, n_WT = 11, p = 0.344454166105802
kfs-mss-msi-inferred-no-cms1: Analyzing wnt NOLBL MT vs WT using Wilcoxon rank sum test: W = 60, n_MT = 14, n_WT = 11, p = 0.373028671422803
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig NOLBL MT vs WT using Wilcoxon rank sum test: W = 55, n_MT = 14, n_WT = 11, p = 0.244076816081124
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1522, n_MT = 35, n_WT = 70, p = 0.0438539651986969
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1134, n_MT = 35, n_WT = 70, p = 0.538434900578318
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1241, n_MT = 35, n_WT = 70, p = 0.916088117248505
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1385, n_MT = 35, n_WT = 70, p = 0.278269566302042
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1196, n_MT = 35, n_WT = 70, p = 0.846386381650853
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1234, n_MT = 35, n_WT = 70, p = 0.953924289291012
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS4 MT vs WT using Wilcoxon rank sum test: W = 293, n_MT = 18, n_WT = 28, p = 0.365711802757514
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS4 MT vs WT using Wilcoxon rank sum test: W = 262, n_MT = 18, n_WT = 28, p = 0.832417783050711
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS4 MT vs WT using Wilcoxon rank sum test: W = 221, n_MT = 18, n_WT = 28, p = 0.496285739627472
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS4 MT vs WT using Wilcoxon rank sum test: W = 213, n_MT = 18, n_WT = 28, p = 0.389994337133986
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS4 MT vs WT using Wilcoxon rank sum test: W = 240, n_MT = 18, n_WT = 28, p = 0.797821082927364
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS4 MT vs WT using Wilcoxon rank sum test: W = 286, n_MT = 18, n_WT = 28, p = 0.454752406365349
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC CMS3 MT vs WT using Wilcoxon rank sum test: W = 114, n_MT = 23, n_WT = 12, p = 0.419612744558763
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A CMS3 MT vs WT using Wilcoxon rank sum test: W = 189, n_MT = 23, n_WT = 12, p = 0.0791312236368835
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 CMS3 MT vs WT using Wilcoxon rank sum test: W = 89, n_MT = 23, n_WT = 12, p = 0.09216335802739
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA CMS3 MT vs WT using Wilcoxon rank sum test: W = 116, n_MT = 23, n_WT = 12, p = 0.460505855461035
kfs-mss-msi-inferred-no-cms1: Analyzing wnt CMS3 MT vs WT using Wilcoxon rank sum test: W = 39, n_MT = 23, n_WT = 12, p = 0.000297263424921607
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig CMS3 MT vs WT using Wilcoxon rank sum test: W = 54, n_MT = 23, n_WT = 12, p = 0.00274021339518951

Computing linear model for CIRC
Computing linear model for HIF1A
Computing linear model for BHLHE40
Computing linear model for CIITA
Computing linear model for wnt
Computing linear model for myc.sig
Computing rectum vs left
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1623, n_rectum = 154, n_left = 20, p = 0.697076920805147
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1745, n_rectum = 154, n_left = 20, p = 0.334586836748315
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1370, n_rectum = 154, n_left = 20, p = 0.423843177968972
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1481, n_rectum = 154, n_left = 20, p = 0.782527064332539
kfs-mss-msi-inferred-no-cms1: Analyzing wnt site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1498, n_rectum = 154, n_left = 20, p = 0.844755540720269
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1534, n_rectum = 154, n_left = 20, p = 0.979296191296886
Computing right vs left
kfs-mss-msi-inferred-no-cms1: Analyzing CIRC site: right vs leftWilcoxon rank sum test: W = 366, n_right = 37, n_left = 20, p = 0.953750712445422
kfs-mss-msi-inferred-no-cms1: Analyzing HIF1A site: right vs leftWilcoxon rank sum test: W = 341, n_right = 37, n_left = 20, p = 0.636517000500124
kfs-mss-msi-inferred-no-cms1: Analyzing BHLHE40 site: right vs leftWilcoxon rank sum test: W = 468, n_right = 37, n_left = 20, p = 0.103405050256096
kfs-mss-msi-inferred-no-cms1: Analyzing CIITA site: right vs leftWilcoxon rank sum test: W = 297, n_right = 37, n_left = 20, p = 0.227581803838232
kfs-mss-msi-inferred-no-cms1: Analyzing wnt site: right vs leftWilcoxon rank sum test: W = 382, n_right = 37, n_left = 20, p = 0.848853451336675
kfs-mss-msi-inferred-no-cms1: Analyzing myc.sig site: right vs leftWilcoxon rank sum test: W = 389, n_right = 37, n_left = 20, p = 0.759117077585492

Plotting CIRC ~ site
Plotting HIF1A ~ site
Plotting BHLHE40 ~ site
Plotting CIITA ~ site
Plotting wnt ~ site
Plotting myc.sig ~ site
There were 36 warnings (use warnings() to see them)
Reading CIRC signature again
R version 3.3.1 (2016-06-21)
Platform: x86_64-apple-darwin13.4.0 (64-bit)
Running under: OS X 10.11.6 (El Capitan)

locale:
[1] C

attached base packages:
 [1] grid      parallel  stats4    methods   stats     graphics  grDevices
 [8] utils     datasets  base     

other attached packages:
 [1] ggdendro_0.1-20      biomaRt_2.28.0       gplots_3.0.1        
 [4] glmnet_2.0-5         doMC_1.3.4           iterators_1.0.8     
 [7] foreach_1.4.3        GSA_1.03             forestmodel_0.4.1   
[10] gridExtra_2.2.1      ggbeeswarm_0.5.3     BayesFactor_0.9.12-2
[13] Matrix_1.2-7.1       coda_0.19-1          caret_6.0-73        
[16] lattice_0.20-34      maxstat_0.7-24       data.table_1.10.0   
[19] corrplot_0.77        gtable_0.2.0         ggplot2_2.2.1       
[22] hgu133plus2.db_3.2.3 org.Hs.eg.db_3.3.0   GSVA_1.20.0         
[25] synapseClient_1.13-4 annotate_1.50.1      XML_3.98-1.5        
[28] AnnotationDbi_1.34.4 IRanges_2.6.1        S4Vectors_0.10.3    
[31] Biobase_2.32.0       BiocGenerics_0.18.0 

loaded via a namespace (and not attached):
 [1] tidyr_0.6.1           splines_3.3.1         gtools_3.5.0         
 [4] assertthat_0.1        vipor_0.4.4           RSQLite_1.1-2        
 [7] quantreg_5.29         digest_0.6.11         minqa_1.2.4          
[10] colorspace_1.3-2      psych_1.6.12          plyr_1.8.4           
[13] GSEABase_1.34.1       broom_0.4.1           SparseM_1.74         
[16] xtable_1.8-2          mvtnorm_1.0-5         scales_0.4.1         
[19] gdata_2.17.0          lme4_1.1-12           MatrixModels_0.4-1   
[22] tibble_1.2            mgcv_1.8-16           car_2.1-4            
[25] pbapply_1.3-1         nnet_7.3-12           lazyeval_0.2.0       
[28] mnormt_1.5-5          pbkrtest_0.4-6        magrittr_1.5         
[31] memoise_1.0.0         nlme_3.1-128          MASS_7.3-45          
[34] foreign_0.8-67        beeswarm_0.2.3        graph_1.50.0         
[37] tools_3.3.1           stringr_1.1.0         munsell_0.4.3        
[40] caTools_1.17.1        RCurl_1.95-4.8        nloptr_1.0.4         
[43] rjson_0.2.15          labeling_0.3          bitops_1.0-6         
[46] ModelMetrics_1.1.0    codetools_0.2-15      DBI_0.5-1            
[49] reshape2_1.4.2        R6_2.2.0              dplyr_0.5.0          
[52] exactRankTests_0.8-28 KernSmooth_2.23-15    stringi_1.1.2        
[55] Rcpp_0.12.9          
